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Abstract 
The chemicals industry provides the foundation of our modern lifestyle, but it has 
far reaching consequences for the planet. It is no longer insider knowledge that 
industrial biotechnology can offer more sustainable solutions to production via 
fermentative biosynthesis. Nevertheless, acceptance of fermentation processes 
is contingent on a single factor: cost-effectiveness. Therein lies the challenge of 
bacterial strain engineering: to generate a cell factory capable of producing the 
target molecule more efficiently than a highly optimised chemical process. 
Rerouting and redesign of bacterial metabolism has become a complex skill, yet 
rational strain engineering is insufficient to garner the required concentrations of 
target molecule. Random and permutatory mutagenesis can be utilised to find 
mutations that will increase target titers but come with a new challenge: testing 
thousands of mutated strains for production capacity. 
In this thesis, we construct systems that can offer solutions to the “problem of 
screening” for biotin biosynthesis in Escherichia coli. After a brief introduction to 
our target molecule biotin with particular emphasis on papers published in the last 
two years, we review the relevant literature on screening and selection. We then 
develop a fluorescent output in E. coli cells based on biotin availability, and adapt 
it for co-encapsulation in alginate beads. Further, we reroute biotin metabolism in 
such a way that strain can only survive if high concentrations of the target 
molecule are available and use this to identify high production variants. Finally, 
we address the problem of false positives with a targeted construct to sieve out 
evolutionary cheaters.  
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Dansk abstrakt 
Selvom kemiindustrien er grundlaget for vores moderne livsstil, har den negative 
konsekvenser for verden. Det er muligt at erstatte kemisk syntese med 
fermenteringsprocesser på en mere bæredygtig måde. Så længe overskud er 
den vigtigste betingelse for produktionen, er det dog svært at forandre industrien. 
Heri ligger udfordringen for industriel bioteknologi: at skabe cellefabrikker der kan 
producere kemiske produkter med højere effektivitet end allerede optimerede 
kemiske processer.  
 
At omdirigere bakteriers metabolisme er blevet et modent forskningsfelt, men kun 
at gøre dette på en rationel fremgangsmåde er ikke godt nok til at nå de høje 
produkt koncentrationer der er brug for. Mutagenese kan også udføres tilfældigt 
eller via permutationer, men dette går hånd i hånd med et andet problem: 
tusindvis af nye stammer skal have deres produktionskapacitet testet. 
 
Denne tese handler om at skabe systemer det kan løse dette screeningproblem,  
især med hensyn til biotin biosyntese i Escherichia coli. Der bliver indledt med en 
opsummeringer af den publiceret litteratur. Derefter beskriver vi et fluorescerende 
konstrukt i E. coli som afhænger at biotin koncentration og som gør det muligt at 
bruge denne biosensor i alginatkugler til high-throughput screening. Derudover 
omdirigerer vi biotin metabolismen, så stammer kun kan overleve hvis de 
producerer høje koncentrationer af biotin. På denne måde kan vi finde gode 
producenter fra samlinger af mangfoldige stammer. Til sidst overveje vi 
problemet med falske positiver og sammensætter et konstrukt so kan sigte 
snydeceller fra. 
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Introduction to the thesis 
Biotin biosynthesis pathway 
Biotin, also known as vitamin B7 or vitamin H, is necessary for all domains of life 
due to its role as a cofactor to carboxylation reactions, including the essential 
acetyl-CoA carboxylase (acc) of central carbon metabolism. The biosynthesis 
pathway in E. coli begins by enzyme BioC to methylate malonyl-ACP, which 
disguises the substrate to enter fatty acid biosynthesis for two rounds of 
elongation (1). The precursor pimeloyl-ACP methyl ester is esterased by BioH (2) 
and serves as a precursor for BioF, which in E. coli can also accept a -CoA 
version of the substrate (3). The penultimate precursor, desthiobiotin, is generate 
by BioA and BioD activity. The final step of the pathway is catalyzed by the BioB 
enzyme, which generally considered the bottleneck of the pathway. BioB is a 
SAM enzyme which utilizes radical chemistry to activate an inert C-C bond for 
sulfur insertion (4). The activity of the enzyme is further characterized by two 
types of iron-sulfuer clusters: [4Fe-4S]2+ is involved in the radical chemistry and 
[2Fe-2S]2+ donates sulfur for the final product (5,6). Each catalytic conversion 
requires regeneration, aided by ferredoxins or flavodoxins (7). The BioB crystal 
structure indicates a dimer with two active sites (6). Experimental data indicates 
one active site is more catalytically active than the other; which may be due to 
regeneration processes (4). Further, feedback inhibition of SAM cleavage 
products has been observed (8), which may contribute to the low turnover rates 
(4). 
Regulation of biotin biosynthesis occurs via the BPL (biotin protein ligase) 
enzyme, which serves two functions in E. coli where it is known as BirA (9). After 
binding to free biotin in the cell, it biotinylates the accB subunits. When no 
peptides this modification, the biotinyl-BirA self-dimerised and binds to the bioO 
operator, which represses the promoters for both halves of the biotin operon bioA 
and bioBFCD (10). 
Previous work on biotin production in E. coli 
Overexpression of in vivo BioB is toxic to the E. coli host (Chapter 3). In a 
separate work, a mutant strain with improved Fe-S cluster supply was identified 
that reduced BioB expressed and enabled higher titers. Therefore we are working 
under two possible hypotheses on why BioB is toxic to the cell: i) overexpression 
depletes intracellular pools of iron-sulfur clusters which impedes other essential 
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processes, ii) incorrectly folded or non-regenerated BioB may release iron into 
the cell which causes the formation of radical oxygen species via the Fenton 
reaction (11). 
Biotin as a target for industrial biotechnology 
The biotin molecule has been of special interest for industrial biotechnology. For 
one, human beings do not have the capacity to synthesise biotin. Due to the 
essentiality of the biotin molecule, the prokaryotic biosynthesis genes may be 
new antimicrobial drug targets (12–15). Secondly, in its role as a vitamin and 
unique co-factor, biotin and its pathway have a number of potential uses. 
Enzymes for polyketide synthesis in E. coli require non-native substrates whose 
heterologous pathways require biotinylation (16). Further biotin levels play an 
important role in fermentation. In yeast, biotin prototrophy is desirable to increase 
financial feasibility of processes (17). Engineering of the biotin pathway has also 
been beneficial for the production of odd-carbon acids in E. coli (18,19), 
streptavidin in E. coli (20),  L-glutamic acid by Coryneform spp. (21), and 
hydrocarbon production in alga Botryococcus braunii KMITL 5 (22). Finally, the 
biotin molecule itself has been the target of extensive research for strain 
engineering (23–28). 
Screening and selection: Applications for vitamin biosynthesis in E. coli 
13 
In Chapter 1 of this dissertation, we review recent developments in selection 
systems with a particular focus on complementing traditional strain engineering 
with synthetic biology tools. We also highlight the difficulties of developing new 
selection systems. Finally we discuss the problem of false positives and selection 
evasion and how some recently published works overcome this challenge. 
In Chapter 2, the native regulation of biotin biosynthesis in E. coli serves as a 
foundation for a biotin-responsive biosensor. This sensor is optimized with tools 
of synthetic biology to generate a robust fluorescence output. To construct a 
high-throughput screening methodology, the sensor is optimized for use in 
nanoliter reactors, which are small alginate beads that can be used for strain 
cultivation. In a proof-of-principle experiment, the highest producers of a mock 
library is enriched using a bead sorter. 
Capitalising on the growth-essentiality of the molecule, we construct two selection 
system for biotin in Chapter 3. In both cases, the cellular demand for biotin is 
increased be decreasing the efficiency of an aspect of biotin metabolism. This 
allows us to identify a high precursor plasmid as well as alternatives to the native 
BioB enzyme. For confidentiality reasons, this chapter is undisclosed. 
Finally, Chapter 4 addresses a central problem identified in Chapter 1: selection 
evasion. We construct a counter-screen for a phenotype we call “tuning” where 
inducible BioB plasmids become inert to the inducer IPTG. In a selection 
scenario, the counter-screen reduces false positives 3-fold. 
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CHAPTER ONE – WIRING CELL GROWTH 
TO PRODUCT FORMATION 
Josi Buerger, Luisa Gronenberg, Hans Jasper Genee, and Morten Sommer 
 
This chapter has been submitted as a manuscript for Current Opinion in 
Biotechnology. 
ABSTRACT 
Microbial cell factories offer new and sustainable production routes for high-value 
chemicals. However, identification of high producers within a library of clones 
remains a challenge. When product formation is coupled to growth, millions of 
metabolic variants can be effectively interrogated by growth selection, 
dramatically increasing the throughput of strain evaluation. While growth-coupled 
selections for cell factories have a long history of success based on metabolite 
auxotrophies and toxic antimetabolites, such methods are generally restricted to 
molecules native to their host metabolism. New synthetic biology tools offer the 
opportunity to rewire cellular metabolism to depend on specific and non-native 
products for growth. 
 
 
 
Graphical abstract 
A diverse library of producers is characterized for production variants. Suitable selection 
systems allow growth only above the threshold, reducing the original library to the top 
producers. 
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INTRODUCTION 
Toxic waste-products and dependency on petrochemicals are notably 
problematic in the chemical synthesis industry. A forward-thinking solution is 
replacing manufacture of materials, medicines, and biochemicals by engineered 
microbial processes. Despite promising benefits and a growing interest, 
widespread industrial implementation of biotechnology has been constrained by 
long development timelines and process economics due to the challenges of 
strain engineering (1). 
The expansion of the DNA modification toolbox allows for genetic editing in a 
targeted, rational manner and this has generated a profusion of engineering 
strategies based on innovation in DNA synthesis and genome editing (2). Yet the 
technology to investigate the resulting clones is often based on low-throughput, 
traditional analytics which cannot address the number of clones present in such 
diverse libraries. 
Biological reporter systems that link product formation to an immediately 
detectable output represent a potential solution to accelerate laborious screening 
protocols using either fluorescence-activated cell sorting (3) or microfluidic 
droplet based sorting (4). However, the reporter systems with the largest 
throughput are those that allow for growth selection by wiring product formation to 
cell growth (5, 6). With a focus mainly on Escherichia coli, we describe recent 
work on applications of conventional selection strategies, review synthetic 
selection systems, and illustrate the difficulties that arise from the construction 
and use of such approaches when deployed for industrial purposes. 
Expanding on conventional selection systems 
Conventional selection systems have been employed in industrial biotechnology 
since the 1970’s and often rely on auxotrophic knock-outs and inhibitory 
molecules to construct dependencies on the target molecule. One 
implementation of gene deletions is the discovery of novel sequences for glycerol 
utilisation using functional metagenomic selections (7,8) (Figure 1A).  
Screening and selection: Applications for vitamin biosynthesis in E. coli 
19 
Figure 1: Utilising auxotrophy for growth-dependent selection 
A - Functional metagenomics selections can be utilized in metabolic engineering. Here, 
DNA fragments of a metagenomic library are selected for improved capacity to utilize 
glycerol as a carbon source (9)(8). 
B - The NAD+/NADH redox requirement of E. coli is utilised to build a strain dependent 
on 1-butanol product formation. As other mixed-fermentation reactions are knocked out 
(grey box), NAD+ can only be regenerated by the 1-butanol pathway (10). 
Auxotrophic strains are a powerful tool for selection, but not all molecules of 
interest are amenable for this type of growth-coupling. Hence, the construction of 
non-native auxotrophies has been pursued. For example, 1-butanol is an 
important fermentation product from Clostridia spp. The native pathway is 
strongly CoA-dependent and this co-factor demand has challenged optimization 
or heterologous transfer. Particularly in E. coli, the metabolic state of high CoA is 
only available during anaerobic recycling of NADH via mixed-acid fermentation. 
In several studies, multiple knockouts of electron acceptors leave 1-butanol as 
the only “NADH outlet” for redox balance under anaerobic growth (10,11). 
Without high flux through the 1-butanol pathway, lack of NAD+ regeneration 
leads to growth arrest. The redox dependency enabled the selection of mutants 
20 
with increased activity of CoA reductase from error-prone PCR mutagenized 
libraries and fermentation titers for butanol were improved to 88% of the 
theoretical yield, reaching 30 g/L. The authors note the suitability of this 
anaerobic growth rescue approach for other NADH-dependent products, 
including lactate, alanine, or succinate.  
The success of an industrial process can hinge on the choice of a suitable 
production strain and overlap of target molecules with metabolic dependency 
should be considered. Computational resources that identify relevant gene 
knock-outs are useful tools (12,13). Predictive genome-scale modelling, 
particularly constraint-based reconstruction and analysis (COBRA) methods, can 
probe further options for engineering a synthetic metabolic link for the compound 
of interest (14–17). These tools are introducing powerful computational resources 
for a technology traditionally based in the lab.   
Another selection approach to strain engineering relies on antimetabolites, which 
are metabolite analogues that inhibit growth (18). This can be due to incorrect 
substrate recognition leading to enzymatic inhibition or disruption of pathway 
regulation. At the correct concentration, antimetabolites force the cell to elevate 
enzyme concentrations or small-molecule products to overcome the inhibition 
burden. For example, three structural antimetabolites enabled selection of strain 
variants with improved production of aspartic acid production (19). In another 
study, riboflavin production was increased to 680 mg/L in Candida famata by the 
use of structural analogues of riboflavin in combination with a colour-based 
screen for the vitamin (20). Antimetabolites can also be used to select for 
increased tolerance to toxic pathway intermediates (21, 22).  
Another type of selection can be imposed by light-excitable quantum cadmium 
telluride dots. The dots generate ROS-stress with the assumption that increased 
tolerance to superoxide is correlated with strong NADPH metabolism, key for 
industrial molecules. A loss-of-function mutation in hdfR was identified using this 
selection and exhibited a 2-fold increase in titers for 3-hydroxypropionic acid, a 
NADPH-limited pathway (23). 
Conventional selections are powerful tools of metabolic engineering and 
expanding them with synthetic biology tools is pushing their versatility even 
further. Muconic acid production in S. cerevisiae was improved three-fold by 
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combining a biosensor conferring geneticin resistance with ALE against 4-
fluorophenylalanine, a competitive inhibitor of aromatic amino acids. The evolved 
strains gave titers of 2.1 g/L (21). Next-generation sequencing gives insight into 
population behaviour (19) and selections can be combined with rational 
engineering (19, 20). Nevertheless, important limitations remain for both 
antimetabolite and auxotrophic selection. Auxotrophic demands exist only for 
essential metabolites and this molecular requirement must lie in the range of 
titers relevant to industrial processes. Unfortunately, this is rarely the case and 
accordingly selection options arising from auxotrophic or inhibitory elements can 
be limited. 
Synthetic coupling of growth to product formation 
Synthetic growth-coupled systems have the same aim as conventional strain 
engineering: identification of high producers from a pool of clones. Starting from 
ligand-responsive switches, gene networks are rewired to monitor the presence 
of target molecules. Gene switches can be based on riboswitches (Figure 2) or 
transcription factors (TFs) (Figure 3), which are then linked to selectable marker 
genes to generate a synthetic or non-natural coupling of growth to product 
formation. 
A seminal selection system utilised the specific response of the NahR TF to 
benzoic acids but not the corresponding aldehydes and coupled it to tetracycline 
resistance (24). The selection identified increased enzymatic activity of xylC, a 
benzaldehyde dehydrogenase from P. putida. A separate system focused on 
lysine production repurposed a riboswitch upstream of lysC to build a 
“Riboselector” such that the presence of lysine reduces toxic expression of tetA 
(25). In four rounds, a proof-of-concept plasmid expressing varying promoter 
strengths for ppc, a key node for the lysine pathway, was enriched. In the same 
work, a tryptophan-specific Riboselector was generated from an aptamer 
functioning as an ON switch. 
A selection system capable of single cell selection was developed for thiamine 
based on the natural ThiM19 riboswitch (6,26,27). In the presence of thiamine 
pyrophosphate, the repurposed ThiM19 riboswitch allows for translation initiation 
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of an otherwise repressed gene. In the study, the switch was coupled to an 
antibiotic resistance cassette, thereby generating a synthetic selection strain 
growth-dependent on thiamine pyrophosphate. To apprehend selection 
escapees, the system was expanded to a second thiamine pyrophosphate 
riboswitch with a different antibiotic resistance gene, which reduced the rate of 
selection evasion by 1,000-fold. The established selection system was expanded 
for xanthine alkaloid selection (6) and applied to metagenomic gene discovery 
and transport engineering (28); demonstrating its versatility and selection power.  
Figure 2: Riboswitch-based selection 
A - A riboswitch is a regulatory element that acts at the level of RNA. Addition of the 
molecule of interest facilitates a structural change of the transcript, which can uncover (in 
this example) an RBS binding site. Shown (left) is a riboswitch without ligand in its OFF 
state so that the selection marker is not active (light grey). The addition of ligand allows 
expression of the selection marker, switching the selection to the ON state (dark orange) 
and allowing growth on selection plates. 
B - In order to generate a robust selection platform that avoids a high rate of false 
positives, Genee et al. (6) place two separate antibiotic resistance cassettes under 
control of independent thiamine pyrophosphate riboswitches, shown to control Selection 
A and Selection B. When no product is present, both riboswitches are inactive. In the 
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case of point mutations, a single riboswitch would lose its selection pressure and allow 
growth on selection plates. Instead, the set-up confers resistance to both selection 
antibiotics only for i) high product concentrations and ii) no loss of selection to activate 
both riboswitches to the ON state. 
As with the NahR example, synthetic selections often utilize TF-based metabolite 
sensing to conditionally express antibiotic cassettes (29–32). A heterologous 
activator and promoter from Thauera sp. conditionally expressed tetA in the 
presence of 1-butanol. This system was used to screen ΔadhE strains with 
plasmid-encoded RBS libraries of heterologous kivD and ADH6 from yeast. 
Increased activity of 35% was identified (30). Two additional systems were built 
to showcase the utility of conditional tetA expression. Firstly, the native E. coli 
system for succinate is regulated by two-component DcuR/DcuS which was 
coupled to tetA expression. Secondly, a system for adipate was built from 
Pseudomonas putida PcaR (30). 
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Figure 3: Transcription-factor based selection 
A - Biosynthesis of a target molecule is coupled to a cognate transcription factor which 
often dimerises to activate or repress a selection marker. Shown is a positive selection 
marker where the presence of the target molecule enables expression of an antibiotic 
resistance marker, allowing only producers to grow on a selection plate. 
B - Negative selection strategies arise from markers with dual effects on the cell. For 
example, gene tetA provides resistance to tetracycline but makes the host cell 
susceptible to NiCl2 toxicity. Negative selection functions ensure that selection “winners” 
have not bypassed the selection pressure. 
C - A workflow for a joint selection system with a positive and negative round is shown. 
From a diverse library, high producers are isolated using a round of positive selection. 
Prior to screening, a negative selection step ensures that the selection pressure has been 
maintained to rule out false positives. 
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Nevertheless, evolutionary escapees can overwhelm selection systems (6,31). A 
“toggled” approach reduced this issue by alternating between positive and 
negative selection rounds (Figure 3C). In addition to enriching for high producers, 
the selection kills the fraction of non-producers that have mutated to evade the 
selection system (33). Using both tolC and kanamycin resistance under a single 
conditional module can generate a kanamycin-resistant strain susceptible to 
colicin-E1 (31). Selection winners can be tested for false positivity by presence of 
colicin-E1 susceptibility. Toggled selection was used to identify a 36-fold 
naringenin producer from genome-engineered libraries using tolC under 
regulation of TtgR. In a second example, tolC regulated by CdaR increased 
glucaric acid 22-fold (31). 
Synthetic selections have also been applied for increased protein expression and 
export. To avoid extraction protocols, secretion is advantageous for recombinant 
protein production. A common approach is to fuse the protein of interest to 
naturally secreted substances such as YebF or OsmY, but this suffers from low 
yields (34). Coupling of YebF to BLiP, a β-lactamase inhibitor protein, conveys 
increased resistance against β-lactam antibiotics. This approach was used to find 
mutants with improved extracellular accumulation of desired proteins in libraries 
with 1012 members (34). 
Development of future synthetic selection systems 
At the heart of many selection systems are genetic switches harvested from 
nature. Yet, the construction of novel selection systems from an identified switch 
is challenging. Nevertheless, recent developments point towards efficient design 
strategies that could be applied to expand the repertoire of selections. 
Despite the prevalence of regulatory elements across diverse genomes, the 
identification or construction of robust metabolic sensors can be laborious for 
either protein or RNA based sensors (35). SIGEX (substrate-induced gene-
expression screening), which places a promoterless reporter gene on either side 
of a randomized metagenomic region in the presence of the desired target, is a 
powerful tool. If a transcription-factor-like sequence is present, the reporter gene 
will be expressed (36). The identification of specific aptamers using SELEX 
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(systematic evolution of ligands by exponential enrichment) and the rational 
design of riboswitches is also not trivial (37,38), as the relationship between 
sequence and function of RNA is not readily discerned (39). Modelling RNA 
sequence to function may assist in the future construction of riboswitch-based 
selection systems by tapping into the power of algorithmic approaches (40,41). 
An approach called “term-seq” identifies natural ribo-regulators in genome 
sequences via early termination events. This methodology is independent of 
evolutionary conservation and can find riboswitches that comparative genomics 
would not (37,38). 
After identification, biosensors can still behave unexpectedly in the production 
host. Insufficient specificity can reduce the applicability of a biosensor. For 
example, the adipate TF-sensor also responded to pimelate (30). Nevertheless, 
non-specific biosensors can be powerful for some applications. One study used a 
proxy biosensor for a pathway intermediate linked to expression of geneticin 
resistance to identify overproduction strains (21). Further, co-cultivation strategies 
can overcome the difficulties of having selection and production in a single strain. 
A ultra high-throughput application of fluorescence markers was used to screen 
multiplexed libraries and identify a B. subtilis producer for riboflavin via alginate 
co-encapsulation with an E. coli sensor strain (42). Proxy biosensors and co-
cultivation may offer solutions when appropriate TFs or riboswitches are not 
available. 
A separate issue concerns biosensor range, i.e. metabolite concentrations which 
lead to discernable signal changes (Figure 4A). Dynamic ranges are rarely 
appropriate for continuous selection systems with increasing titers. A fluorescent 
biosensor for L-valine production in Corynebacterium glutamicum enabled 
increased titers by 25% for 5 rounds of FACS sorting before the upper detection 
limit had been reached (43). The 1-butanol sensor described above (30) could 
not be used above 25 mM metabolite concentration. The glucaric acid system 
(31) also reports the range’s limitations. A proffered solution is transport
regulation to direct the rate of molecule uptake and thereby the dynamic sensor
range (31) (Figure 4B). A further strategy is the construction of molecular buffer
systems. In this work (44) a TF is split into two functional domains, DNA-binding
or activation. An excess of DNA binding domain mimics chemical pH buffer
systems to generate a robust signal and protection against promoter leakiness.
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Figure 4: Tuning selection systems and limiting evolutionary escape  
A - The graph indicates output of a selection marker based on metabolite concentration.
Two saturation points are indicated; a lower threshold where decrease in production does 
not lead to decrease of output (orange dotted line) and an upper threshold where 
increase in production does not lead to increase in output (blue dotted line). The coloured 
boxed below show the effect of high or low production at each of the three phases, 
emphasising the importance of biosensor range to get a screenable output correlated with 
product formation.  
B - As in Raman et al. (31), engineering of transporters can shift the functional range of a
selection system. Two sensors are shown, with (left) or without (right) active import, which 
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changes the conditional expression of the selection marker even though the extracellular 
metabolite concentrations remain the same. 
C -  Loss of selection via evolutionary escapees
Overview of a cell with a generic growth-couples selection system: a transcription factor 
binds to the molecule of interest, dimerises, and activates the expression of an antibiotic 
resistance cassette. Numberings 1-5 illustrate potential mechanisms of selection 
escapee. These mechanisms would allow the cell to survive an antibiotic challenge even 
if it did not produce the molecule of interest. 
Finally, a major obstacle is the intrinsic response of biological systems to 
overcome selective pressure (45,46). A single point mutation in promoter regions 
can confer loss of selection, which provides the escapee with unrivalled growth 
advantage compared to the remaining population (Figure 4C). The thiamine 
riboswitch gave a false positive rate of 10E-3 for an early, unoptimised selection 
construct (6). In nature, genetic networks often display redundancy so that their 
function is robust to mutagenic effects. Gene duplication is a strong opposition to 
genetic drift, and this strategy can be utilised to reduce selection escape. 
Redundancy within selections can consist of two antibiotic resistance cassettes 
under one regulator (6) or single genes with two controllable outputs (33) . 
Raman et al. (31) demonstrate the versatility of selection doubling by expanding 
ten different biosensors in a modular way. The concept of redundancy is a 
powerful addition to the toolkit of selection systems. 
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CONCLUSION 
Within industrial biotechnology, the need for robust, modular, and usable 
selection systems arise with the ability to manipulate, design, and multiplex the 
DNA code. Selection strategies of conventional strain engineering can identify 
genotypes with higher production capacity and are amenable for expansion with 
modern techniques. The further development of synthetic circuits to wire growth 
to product formation allows for the characterization of millions of genetic variants, 
with particular applications to generate sustainable cell factories for a greener 
chemical industry. Nevertheless, the success of synthetic selection systems will 
rely on overcoming the challenges of their construction and application: 
identification of relevant conditional modules, solving issues of specificity and 
range of in vivo biosensors, and addressing the false positives and negatives that 
arise from loss of selection. 
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CHAPTER TWO – SCREENING IN 
NANOLITER REACTORS WITH A BIOTIN 
BIOSENSOR 
This chapter is printed in its original form. 
Abstract 
Biological reporter systems that link product formation to an immediately 
detectable output represent an acceleration to laborious screening 
protocols. With some modification, biosensors are amenable for high-
throughput screening using alginate beads (nanoliter reactors) to 
characterise the production capacity of thousands instead of hundreds of 
clonal variants. Here we present the development of a biotin-sensitive 
biosensor, optimisation of a nanoliter reactor protocol, and proof-of-
concept screening of a library. 
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INTRODUCTION 
Transcription-factors as stepping stones to biosensors 
Biosensors are a versatile tool to identify high producers from a library of clonal 
variants (1). At their heart, biosensors have a domain to detect the metabolite of 
interest and a conditionally expressed, readily discernible output. Output domains 
are often well-characterised genetic markers such as assayable lacZ (2) or 
fluorescent proteins, e.g. GFP from jellyfish Aequorea victoria (3). Detection 
domains often rely on repurposing gene regulation, as many genetic events are 
coupled to metabolite sensing. In particular, transcription factors and their paired 
promoters are key for the construction of novel biosensors. For example, a 
transcription factor PadR from B. subtilis for p-coumaric acid was expressed in E. 
coli to control the expression of a yfp to generate measurable fluorescence only 
in the presence of p-coumaric acid (4). 
To act as a robust biosensor amenable for nanoliter reactors, a sensing-output 
domain must fulfill a number of requirements. The first requirement is 
orthogonality and suitability with respect to host metabolism. Orthogonality is the 
capacity for seamless recombinant expression. Transcription factor - promoter 
pairs should be transferable to multiple hosts without change in functionality. The 
transfer should not interact with or disrupt native metabolism or regulation. This is 
of particular relevance for metabolic engineering: the presence of a biosensor 
should not encumber the rational restructuring towards the molecule of interest. 
The choice between native and recombinant sensing-output domains must be 
deliberated. Heterologous constructs expand the range of sensible molecules, 
but the effect of synthetic expression can be problematic (reviewed e.g. 5) 
However, native transcription factors often act as global regulators within host 
metabolism so that their overexpression impacts the global transcriptome (5). In 
situations where a native TF does not affect regulation, the native concentration 
may be insufficient for signal mediation (20). Not only the effect of the sensing 
domain has to be taken into consideration: fluorescent proteins can also impact 
bacterial physiology, e.g. mCherry can give false OD measurements (33).  
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Table 1: In vivo biosensors using TF in E coli published in the last 5 years 
Target molecule Genetic architecture Application 
N-acetylneuraminic acid Engineered promoters that interact with 
native NanR to express mKate2 (5) 
Identify high N -acetylneuraminic 
acid producers 
Acrylate AcuR from Rhodobacter sphaeroides 
and sfGFP (6) 
Arsenite Native ArS repressor and operator 
control egfp (7) 
Arsenite 
Cadmium CadC homologue from Bacillus 
oceanisediminis 2691 and GFP (8) 
Heavy metal sensing in 
microfluidics application 
Cellubiose CelR from Thermobifida fusca with GFP 
(1) 
Biosensor for detection of 
cellulolytic activity 
Clorpyrifos (CPF) Cognate promoter chpA and activator 
ChpR from Sinorhizobium meliloti with 
fluorescent output 4-MU activated by a 
native sulferase (9) 
Pesticide detection in 
environmental samples 
p-coumaric acid PadR from B. subtilis activates yfp 
expression (4) 
3,4-dihydroxy benzoate pcaU and promoter from Acinetobacter 
sp. ADP1 with GFP (10) 
FACS to improve sensor 
Doxycycline TetH/TetR modules from Haemophilus 
somnus 2336 and GFP (11) 
Selective detection of 
tetracycline variants 
Erythromycin Native MphR and sfGFP (6) 
Formaldehyde Native FrmR and error-prone PCR 
library of formaldehyde responsive 
promoters with GFP (12) 
FACS to improve sensor 
Fructose-1,6-
bisphosphate 
Cra activator and ppsa promoter with 
GFP (13) 
Monitor effect of different carbon 
sources or mevalonate 
production on glycolytic flux 
Glucarate Native CdaR and sfGFP (6) Monitor flux in glucarate 
production 
Heme Heme-binding domain cytochrome b562 
from Saccharomyces cerevisiae linked 
to EGFP and mKATE2 (14) 
Study of heme metabolism 
3-hydroxypropionate Native prpR, pprpR, and pcs from 
Chloroflexus aurantiacus or a version 
with acuR from Rhodobacter 
sphaeroides (15) 
Identify optimal conditions for 3-
HP production 
Itaconic acid YpItcR/Pccl from Yersinia 
pseudotuberculosis with RFP (16) 
Identify suitable gene expression 
for biosynthesis of itaconic acid 
in E. coli 
Lactams (ε-caprolactam, 
δ-valerolactam, 
butyrolactam) 
Activator-promoter pair ChnR/PB from 
Acinetobacter sp. strain NCIMB9871 
(17) 
Lead CadC homologue from Bacillus 
oceanisediminis 2691 and GFP (8) 
Heavy metal sensing in 
microfluidics application 
Macrolides Native MphR responsive to e.g.  
erythromycin, josamycin, oleandomycin, 
Error-prone PCR of the activator 
binding domain combined with 
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narbomycin, methymycin and pikromycin 
with GFP (18) 
FACS generates increased 
activator specificity 
Maltose Synthetic fusion of DNA-binding zinc 
finger module with protein for maltose 
binding (19) 
Maltose 
Monosodium 
methylarsonic acid 
(MSMA)  
Sequence-modified ArsR of 
Acidithiobacillus ferrooxidans and 
according operator controlling GFP 
expressed (20) 
In vitro biosensor for herbicide 
detection 
NADPH SoxR and eyfp (21) Screen a mutant enzyme library 
for improved activity 
Naringenin FdeR from Herbaspirillum seropedicae 
SmR1 and fluorescent marker (22) 
Identify suitable biosynthesis 
genes for flavonoid production 
Naringenin TtgR from Pseudomonas putida and 
sfGFP (6) 
Nickel RcnR C35A and rcnA promoter with lux 
reporter gene in E. coli TD2158 (23) 
Lower limit of detection for nickel 
detection in drinking water 
p-nitrophenol Mutated PobR from Acinetobacter with 
GFP (24) 
Characterise hydrolysis activity 
on insecticide 
2-oxaloacetate 2-oxaloacetate binding domain found in
NifA from Azotobacter vinelandii with yfp
(25)
Study effect of nutritional 
changes on metabolite pool in E. 
coli 
Phenol DmpR activator with GFP (26) Evolve novel tyrosine-phenol-
lyases 
Phenylalanine TroR activator with mtr promoter 
activates Venus (27) 
Screen promoter library for 
biosynthesis of phenylalanine 
Phenylalanine TyrR activator and tyr promoter with YFP 
(28) 
Screening of a mutagenized 
library with RBS variants for 
production in E. coli 
Qercetin and kaempferol QdoR from Bacillus subtilis and 
fluorescent marker (22) 
FACS of kaempferol producers 
Shikimic acid Mutated HucR and promoter from 
Deinococcus radiodurans expressed 
RFP (29) 
Improve flux into shikimic acid 
pathway in E. coli via engineered 
AroG 
Triacetic acid lactones Various AraC mutants activate GFP (30) 
and further engineering (31) 
FACS to diversify substrate 
recognition and carry out 
metabolic engineering for TALs 
A second requirement is suitable dynamic range and response for the desired 
application. The dynamic range of a sensor is the concentration of metabolite 
which generates a detectable difference in output, also called the transfer 
function (6). The relevant concentration will vary between intracellular and 
extracellular applications depending on molecular transport (34). For example, a 
promiscuous biosensor can require different amounts of two flavonoids for the 
minimal activation concentration: in fact a 2-fold increase between kaempferol 
and quercetin (22). Further, a study with identical sensor plasmid architecture but 
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different heterologous sensing domains showed that the optimal measurement 
time ranged from 1 - 6h (6); indicating that time is a relevant factor for range.  
Thirdly, a sensor must show the appropriate target specificity. Conditional output 
expression should occur only in the presence of the metabolite of interest. 
Adequate specificity is pressing concern for many applications: for example, to 
reliably detect herbicides using a biosensor, detection needs to be restricted to 
the biologically toxic trivalent arsenic species (MSMA and roxarsone) but not 
inorganic arsenic (20). Hence, biosensors are often tested for inertness to 
structurally related compounds: for example, a cellubiose biosensor was tested 
for response to the structurally similar glucose polymers and disaccharides (1). 
Finally, the inherent susceptibility of biological systems to genetic drift and 
mutation pressures should not be disregarded, in particular if a sensor will be 
used in vivo over extended cultivation time. This has been already discussed in 
Chapter 1. 
Applications - nanoliter reactors 
Once a robust, orthogonal biosensor has been developed, it may still require 
further optimisation for its desired application, often the interrogation of large 
clonal libraries. Although library screening with a sensor can be done via strain 
cultivation and a fluorescence plate-reader, throughput of this approach is limited 
to 103 per day for manual workflows and 104 for automated protocols. A solution 
is the use of droplet or micro-bead technology. Sorting with nanoliter reactors can 
interrogate up to 106 events per day, an incomparable advantage for screening 
large libraries.  
Nanoliter reactors or alginate beads1 are formed from an anionic polymer isolated 
from brown algae. They form a viscous substance that can be mixed with 
biological matter to generate stable globules by passing through an extrusion 
nozzle, separation by directed air-flow, and hardening in CaCl2 buffer (35). This 
generates individual, separated reactors that can isolate proteins, chemical or 
enzymatic reactions, proteins, and entire bacterial cells. When coupled with a 
measurable output and a sorting device, encapsulation are an excellent tool for 
1 Also referred to as hydrogels or microgels 
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screening large libraries with wide applicability. Various whey proteins were 
analysed in the beads and tested for stability (36), a laccase from the white-rot 
basidiomycete Coriolopsis gallica was identified for superior dye degradation 
ability, and the GFP variant sfGFP was optimised for acidic conditions (37). Even 
structurally sensitive RNA aptamers have been successfully encapsulation and 
sorted in nanoliter beads (38). 
Whole-species encapsulation include Pseudomonas aeruginosa, E. coli, and 
Laccococcus spp. Whole-cell biocatalysis for target products is a powerful 
implementation of alginate beads, particularly for E. coli. For example, production 
of l-xylulose was achieved by expressing recombinant l-arabinitol dehydrogenase 
and NADH oxidase to regenerate the needed co-factors (35). Further applications 
include α-ketoisocaproate production (39), cadaverine production (40), and even 
high-throughput colony PCR (41). Within strain engineering, the use of alginate 
beads can be developed further beyond cell immobilisation. Alginate beads can 
serve as nanoliter reactors for multiple strains and species. For example, a library 
of Bacillus subtilis vitamin B12 producers was screening with an FMN-responsive 
riboswitch expressed in an E. coli strain. Using FACS-like sorting, highly 
fluorescent beads are isolated to provide the high production variants (38). Here 
we apply the co-cultivation strategy to enrich E. coli strains with plasmids for 
biotin production using an E. coli biosensor. 
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MATERIALS AND METHODS 
Bacterial strains and plasmids 
Escherichia coli strain One Shot™ TOP10 (Invitrogen) was used for cloning and 
plasmid extraction. Biosensor characterisation was carried out in E. coli strain 
BW25113 from the Keio collection (1) as well as JW3803-2 ΔyigM with 
kanamycin cassette removed. Production strain for the cultivation was carried out 
in BS15752. Sensor strain in the NLRs was BW25113 29Δglk2Δpts1ΔmanZ1. 
Table 2: Plasmids constructed in Chapter 2 
Plasmid Construction 
pBS195 Amplification of sfGFP (2) and ampicillin resistance cassette from 
pBS046 (oBS20, oBS21) 
Amplification of colE1 from pBS19 (pZA31luc from EXPRESSYS) 
(oBS1105, oBS1107) 
Amplication of bioO-bioA region from E. coli MG1655 (oBS1161, 
oBS1162) 
pBS249 Amplification of sfGFP and ampicillin resistance cassette from pBS046 
(oBS20, oBS21) 
Amplification of colE1 from pBS19 (pZA31luc) (oBS1105, oBS1007) 
Amplication of bioO-bioB region from E. coli MG1655 (oBS768, 
oBS789) 
 pBS334 
 Amplification of p15A from commercial vector pBAD18 (ThermoFisher) 
(oBS1172, oBS1173) 
 pBS411 
 Amplification of smR resistance cassette from pBS259 (pMA7SacB (3)) 
(oBS1159, oBS1160) 
pBS459 - 
pBS464 
Amplication of mCherry with library of promoters (oBS1440, oBS1435) 
Chemicals 
Chemicals were purchased from Carl Roth GmbH unless otherwise noted. Biotin 
(Sigma-Aldrich) and DTB (Sigma-Aldrich) were made as 100 mM DMSO stock 
solutions. Antibiotics ampicillin, kanamycin, zeocin, and spectinomycin (Sigma-
Aldrich) were dissolved as 1000x stock solutions in MQ. Plating experiments were 
carried out by mixing 2x-concentration MOPS or LB with 3% agar (Sigma-Aldrich). 
All solvents were handled according to manufacturer’s instructions. 
2 Strain genotypes are available in the Annex. 
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Media and cultivation 
Molecular biology protocols were carried out in 2xYT made from 16 g tryptone, 10 
g yeast extract, and 5 g NaCl per liter; or SOC media containing 20 g tryptone, 5 g 
yeast extract, and 0.5 g NaCL per liter, supplemented with 0.5 mL 2 M MgCl2 and 
1 mL 20% D-glucose per 100 mL before use. Biosensor characterization was 
carried out in minimal MOPS (e.g. 4) containing 10x MOPS, 10 mL 0.132 M 
K2HPO4, 500x vitamin solution, and 10 mL 20% D-glucose. Nanoliter optimization 
was carried out in M9 containing 10x M9 salts (Sigma Life Sciences), 20 mL 20% 
D-glucose, 0.1 mL 1 M CaCl2, 2 mL 1M MgSO4, and 0.5 mL trace element solution.
CDM (chemically defined media, recipe in Annex) was also used. Stock protocols
are placed in the Annex.
Molecular biology techniques 
DNA fragments were generated by PCR from genomic DNA (E. coli MG1655 or 
BW25113) or plasmid DNA using primers synthesized by IDT or Eurofins for 
Gibson Assembly (5) or USER cloning (6). USER primers were designed with 
AMUSER software (7). PCR experiments for Phusion U polymerase (Thermo 
Fisher) contained HF-buffer (Thermo Fischer), dNTPs (Thermo Fischer), 0.02 U/µL 
polymerase, 0.5 µM of each primer, and template DNA at concentrations per 
manufacturer’s instructions. PCR cycles followed PhuU amplification protocol in a 
Ristretto thermocycler (VWR). PCR products mixed with 6x DNA Gel Loading Dye 
(Thermo Fischer) were subject to gel electrophoresis in 1% agarose (Lonza) with 
SYBR Safe DNA Gel Stain (Thermo Fischer). Electrophoresis in TAE buffer diluted 
from 10x stock was carried out at 90 V, 400 mA for 35 minutes. Gels were 
visualized using blue light and 1 kB GeneRuler DNA ladder (Thermo Fisher), 
excised if necessary, purified with appropriate Cycle Pure Kits (Omega), and 
concentrations determined via Nanodrop (MySpec VWR). Plasmid assembly was 
carried out according to USER (6) or Gibson assembly (5) manuals. Strains were 
prepared following protocols for chemical competency (8) or electroporation (9) 
and transformed with ligated or plasmid DNA. Plasmid extractions were performed 
with E. Z. N. A. Plasmid DNA Mini Kit (Omega). Sanger sequenced was performed 
with Mix2seq kits (Eurofins). 
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Characterisation of growth and fluorescence 
Strain characterization was carried out 96-well lidded deep-well plates 
(Enzyscreen). Colonies were inoculated into precultures of the respective media 
and incubated at 37 °C for 18-20 h at 274 RPM (Innova Thermo Fischer). OD was 
determined at a 1:10 dilution using a plate reader (Multiskan FC, Thermo 
Scientific)3. Production cultures were inoculated at a concentration 1:100, 
normalised by preculture OD where required. Strain fluorescence was determined 
with a plate reader (VarioSkan LUX, Thermo Scientific) at emission/excitation at 
485/518 nm or 575/618 nm for sfGFP and mCherry, respectively. Kinetic data for 
growth and fluorescence were obtained by cultivation in microtiter plates (greiner 
bio-one) with porous seals (BreatheEasy; Diversified Biotech). Measurement was 
carried out every 10 minutes.
Bioassay 
To assay biotin concentrations in supernatant samples, growth of a ΔbioB strain 
with zeocin resistance to extracellular biotin at various dilutions was used. Biotin 
standards between 0.5-30 µM and supernatant samples were added to each 
master plate, which was typically diluted and inoculated 1:10 with the bioassay 
strain at a final dilution of 7,500 – 25,000. As a correlation between growth and 
biotin availability for E. coli is obtainable between ~50-500 pM, multiple dilutions 
are necessary.  Examples below shows growth response to dilution range at 
10,000x. 
3 Values were converted to cuvette OD in all cases using previously determined 
conversion rate: CuvetteOD = MULTISKAN/0.2569 - 0.0001 
y = 0.0637x - 0.0146
R² = 0.9964
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Encapsulation, extraction, and analysis of nanoliter 
reactors 
For encapsulation at respective λ = 300 and λ = 0.3, glycerol stocks of sensor and 
production strains were diluted in final volume of 2 mL sterile 0.85% NaCl, 
vortexed, and added to 8 g 2.5% alginate (Sigma Aldrich). Using a plastic syringe, 
mixture was pumped through a laminar jet-break encapsulator (Nisco Engineering 
AG) at flow rate 2 ml/min, mode P9, and a 0.35 mm nozzle into stirred 100 mM 
CaCl2 for hardening. After 15 minutes, beads were washed with 10 mM CaCl2 and 
soaked in respective media. Excess media was thoroughly washed off and beads 
allowed to dry prior to incubation in liquid (2mL 10 mM CaCl2) or hydrophobic (50 
mL heavy mineral oil with 2% ABIL 90 and 0.05% Tween 20) phase. 
Encapsulations were incubated at 37 °C 200 RPM. For imaging and COPAS 
sorting, beads were extracted from hydrophobic phase via centrifugation at 80g for 
10 minutes, then washed with 10 mM CaCl2. Fluorescence assay and sorting was 
carried out with a COPAS (Union Biometrica). Identified beads were sorted into 96-
well deep-well plates containing minimal media with glucose which does not allow 
sensor strains to grow.  
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RESULTS 
The native regulatory elements of E. coli biotin 
biosynthesis are amenable to biosensor construction 
The native operon structure of biotin biosynthesis in E. coli is separated into three 
transcription events at two genomic loci (42). The bioABFCD region is strictly 
regulated due to the high synthesis cost of the biotin molecule. We utilise BirA, 
the repressor protein of the operon promoters to build a biotin-responsive 
biosensor. To ensure functionality of the operator site, output gene sfGFP4 (43) is 
placed after the first ten amino acids of the regulated gene. Given the 
bidirectional nature of the bioO operator (Figure 1), two promoter regions PBA and 
PBB were compared for signal mediation (Figure 2, V1). The response of V1 
constructs to biotin concentrations was poor, with large variability between 
replicates (CV>50%) and small difference between on and off states. 
Comparison of the promoter options (Linear fit of 24 data points, R2=0.52 
compared to R2=0.28 of PBA) indicated PBB as a candidate for further 
optimisation. 
It was hypothesised that differences in plasmid copy number between individual 
cells could account for noise in GFP output (e.g. 20). A common normalisation 
approach is to constitutively express a second fluorescent marker, in this case 
mCherry. The sequence was added under the control of constitutive promoters 
from the Anderson library (45) at three different expression strengths 
(BBa_J23105 with 623 AU,  BBa_J23106 with 396 AU, BBa_J23117 with 162 
AU). At the lowest expression level, mCherry was inert to biotin concentrations 
(data not shown) and used to build V2. The GFP output is normalised by overall 
expression capacity such that the subsequent transfer function of the sensor is 
given by the GFP:mCherry (Figure 2, V2). 
4 Superfolder GFP 
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Figure 1: Native biotin regulation is engineered to build sensor plasmid pBS453
Left - Transcription of biotin biosynthesis is tightly regulated in E. coli. In conditions of 
excess biotin (shown in yellow), transcription factor BirA binds the metabolite and self-
dimerises (complex shown in darker grey) to bind and repress the bioO operator 
encompassing promoters for bioA and the bioBFCD operon. When the bioO domain is 
free, transcription occurs (yellow arrows).
Right - Basic plasmid template of V3 with p15A origin of replication and spectinomyin 
resistance cassette smR is used to express bioO, the operon responsive to dimerised 
BirA-biotin complexes. The sfGFP output is fused to the first 10 amino acids of the BioB 
sequence to ensure orthogonal transfer of the repressive region. mCherry is added to the 
plasmid under a medium level promoter to normalise for plasmid copy number and the 
relaying transcription factor birA is added in the same operon. Resulting plasmid pBS453 
has a total size of 4982 bp. 
To address the noise of the V2 construct in the off state (concentrations 101-106 
µM), we considered the importance of the BirA transcription factor for signal 
mediation. Each bioO repression event requires two biotin molecules and two 
BirA proteins for dimerization and the copy number of p15A origin of replication 
lies at ~20 as well as the bioO on the genome. Predicted cellular levels of BirA 
as a non-abundant transcription factor are <50, which led us to hypothesise that 
at high biotin levels, BirA concentrations may be limiting to relay the signal. The 
BirA sequence was added to the V2 construct by placing it in an operon with the 
mCherry gene with a DNA spacer5. An RBS library of 6 members was tested at 
predicted TIR6s 19, 95, 308, 337, 949, and 1255 (46). The addition of the 
transcription factor did not shift the range of the sensor, but more stable on and 
off states were observed for predicted RBS strength of >300 (V3, right). At a 
lower RBS, the quality of the GFP signal was in fact reduced (V3, left) Finally, an 
option to increase the range of the sensor was tested by transferring the plasmid 
into a knockout of the E. coli biotin importer yigM. This shifted the range of the 
5 gtttggttgaattc 
6 Translation initiation rate 
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sensor 100-fold (Figure 2, bottom): both sensors are in the off state at 1000 µM; 
the yigM WT is on at 100 µM whereas yigM KO is on at 0.1 µM extracellular 
biotin. Further, the relative difference between the on and off fold states 
compared to V1 was increased 100-fold (7 to 70 normalised fluorescence units). 
Figure 2: Stages of development for a biotin-responsive biosensor 
Top row - A plasmid-based system containing native E. coli biotin operator 
regulation expression of GFP gave an average signal (grey line) only weakly 
correlated to extracellular biotin concentration with low reproducibility across 
replicates (yellow data points, V1-A, B). Improvements to the sensor are shown 
by inclusion of mCherry (V2) and transcription factor BirA (V3, efect of two RBS 
strengths is shown). Fluorescence data is normalised to off state; axes are 
identical. 
Bottom graph - The optimised sensor construct generates a clear GFP output 
(n=3) to biotin concentrations and improves the signal-to-noise ratio as well as 
expanding the range of output. 
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Co-cultivation in nanoliter reactors 
Factors for co-cultivation protocol 
In collaboration with FGen GmbH we developed our biotin biosensor for high-
throughput sorting in nanoliter reactors. An analogous biotin sensor was built by 
FGen with increased sensitivity, ampicillin resistance, and reverted output with a 
tetR repressor module (range 0-50 nM in yigM WT, 0-250 nM in yigM KO7). The 
modified sensor plasmid sAS278 was expressed in a glucose inert strain 
BW25113 29Δglk2Δpts1ΔmanZ1. Genetic engineering of carbon utilisation 
allowed for co-cultivation of the sensor strain with a second E. coli production 
strain. The biotin production strain was grown on glucose (0.001%) while the 
sensor grew on any other usable carbon source supplied, in this case 1% 
galactose. Within defined minimal media (M9 or CDM), both producer and sensor 
strain grew, albeit to different colony size (Figure 3). Co-cultivation for sorting 
demands a single producer colony in each bead filled with ~300 sensor beads. 
Given the occupation distribution of strains in beads, average occupation λ = 0.3 
ensured minimal doubly occupied beads. As shown in Figure 3C, sensor 
fluorescence positively responded to extracellular biotin.  
7 Range determination is alginate beads is heavily dependent on experimental conditions. 
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Figure 3: Media and protocol optimisation for co-cultivation 
A - Average colony diameter is determined at 8h and 24h after encapsulation. For each sample, 5 
colonies in standard beads with single occupation were measured (x and y axis). To correct for 
potential subjectivity of this measurement process, the furthest outlier from the average was deleted 
from each measurement time-point. Outliers identified by: largest of [|(AVERAGE(x-measurement; y-
measurement))-AVERAGE(all data points from that time-point)|]  
B - Bead occupation of a producer strain is determined by counting colonies in a total of 102 beads 
(work carried out. 
C-  Brightfield microscopy and fluorescence images of beads co-cultivating a biotin-responsive sensor,
E. hacoli strain BW25113, and extracellular biotin. Beads were incubated in hydrophobic p se for 48h
and extracted for imaging. 
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Library for proof-of-concept screening 
To showcase the suitability of a TF biotin sensor in nanoliter reactors, we 
assembled a mock library for biotin production. The E. coli biosynthesis genes 
were expressed on a low copy-number plasmid with the same antibiotic 
resistance as the sensor plasmid (ampR). Diversity of the library is due to two 
alternative operon structures, native arrangement of E. coli (CU plasmids) or a 
synthetic operon structure (DU plasmids). In each case, the bioH sequence is 
placed after an RBS library to balance with the remaining pathway. The 
bottleneck BioB sequence is also expressed separately in each case. Plasmids 
were transformed into production strain BW25113 Δbio*. 
Figure 4: Proof-of-concept library 
Left - Biotin titer for three representative library members. Titers (n=4) were determined 
using the bioassay protocol. 
Right - Plasmid architecture of combinatorial library used in the co-cultivation set-
up.  Biotin biosynthesis genes are expressed in native (CU) or synthetic (DU) structures 
with bioH placed after an RBS library. In each case, bioB is expressed separately under 
IPTG induction. Titer of DU.8 was below detection. 
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To determine suitability of the mock library for encapsulation, growth behaviour 
was monitored by measuring colony diameter of each library member and the 
background strain (Figure 3A). No statistical differences in colony size was 
observed at 8h or 24h. The larger error bars observed after 24h are attributable 
to high levels of variability in the measurement protocol. Overall the library was 
deemed appropriate for a proof-of-principle sorting experiment. 
COPAS sorting and verification 
Figure 5: Library before and after COPAS sorting 
Left – The distribution of strains carrying plasmids DU.4 (low), DU.8 (medium), and CU.4 
(high) before encapsulation. Note that the schematic is not based on actual data and 
serves to visualize the enrichment. 
Right - Production values of 70 strains recovered after COPAS bead sorting and grown in 
minimal media. Production values grouped in two sets corresponding to the expected 
production values of DU.8 and CU.4. Control was CU.4 plasmid not subject to sorting. 
Plasmids were confirmed with sequencing, corresponding to an enrichment of the high 
producers from 20% to ~50%.  
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Sensor strain and library were co-encapsulated and incubated for 48h. Library 
members were mixed in a ratio of 2:2:1 (DU4:DU8:CU4) to simulate biological 
diversity. As a control, library members were also co-encapsulated individually. 
The resulting fluorescence was imaged after 48 h in hydrophobic phase. Using a 
COPAS flow pilot (Union Biometrica), 6000 events were quantified for 
fluorescence following time-of-flight size gating. Top 5% of library beads were 
sorted into recovery media. To isolate producer strains, beads were incubated in 
minimal media with glucose as the sole carbon source. Out of 76 sorted events 
from the top 5% gate, 74 could be recovered (OD = 2.85 ±0.22), and 70 tested 
for production using the bioassay (Figure 5), corresponding to sample loss <10%.  
As strain CU.4 produced 2-fold more than DU.8 and had a mean fluorescence of 
3976 AU compared to 1080 AU for DU.8, we concluded that the production was 
stable both before and after sorting (compare Figure 4). After sorting, no low 
producers (DU.4) were recovered. For strains carrying plasmid CU.4, sorting 
resulted in an enrichment of 20% to ~50% (p<0.0001, unpaired t-test with 
Welch’s correction). Plasmid identity was confirmed via sequencing. The proof-of-
concept sorting was deemed successful. 
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DISCUSSION 
The use of nanoliter reactors to interrogate production libraries combines the 
advantages of selection - efficient identification of high producers due to high-
throughput - with the advantages of screening - relative ease to establish and 
ability to characterise the whole library. In case of sensitive enzymatic steps, 
immobilisation in alginate can even increase yields (39). Other options of high-
throughput screening such as FACS, microfluidics, and droplet sorting, offer 
similar advantages. Nevertheless, establishing protocols for nanoliter reactors is 
a non-trivial step of successful screening. Depending on the demands of the 
screen, factors such as pH (36), bead size (41), ratio of alginate to sample (47), 
and temperature (40) should be considered. 
 
Challenges of encapsulating in nanoliter reactors 
In this Chapter, we detailed the construction of a novel transcription factor-based 
biosensor for our target molecule. Although utilising native gene expression 
events is common to build sensor domains, we obtained only a weak GFP 
response to biotin concentrations in initial construct V1. The signal was amplified 
and stabilised by the combination of synthetic biology tools and overexpression of 
the transcription factor. This emphasised the relevance of TFs for fine-tuned 
signal mediation in orthogonal sensors (20). It should be addressed that a well-
functioning TF-based biosensor is not immediately amenable for alginate bead 
application. In our case, additional modifications were necessary to transfer the 
sensor functionality. Generally, the required sensor range for a bead can be 
entirely different to a liquid cell culture. The ratio of sensor occupation to 
producers in a bead must be considered. Secondly, media demands for bead 
stability and engineering of central carbon metabolism of the sensor will also 
affect the transfer function. Co-cultivation approaches in particular require sugar 
orthogonality, which can affect growth, production, and sensing behaviour of both 
strains. Thirdly, stability of production can impact the screening especially if 
target molecules induce toxicity at high concentrations (6). Utilising KO strains 
can help to maintain production plasmids in case of instability (12). Finally it 
should be noted that the system detailed here, as opposed to previously 
published two-species co-cultivation (38), is a co-cultivation of two E. coli strains 
with its own particular challenges.  
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Overall we gated and analysed 5% of the library, leading to an enrichment from 
20% to 50% of the highest producer. To enrich further, more stringent sorting 
conditions could be considered. However due to the nature of bead occupation 
(Poisson distribution), approximately one third of beads will always remain 
unoccupied (only sensor is present). Therefore, a gate decrease to less than 
2.5% is barely feasibly, as the overall sorting time increases exponentially. If a 
higher percentage of CU.4 is desired from the sorting, multiple enrichment rounds 
need to be carried out instead. The suitability of this system for high-throughput 
library screening will depend heavily on the characteristics of the library.  
Characterising the mock library 
To elucidate the genotypic cause of production differences between DU and CU-
plasmids, we sequenced the plasmids after sorting. Firstly, we recognise that the 
native biosynthesis operon outperforms the refactored pathway, as has been 
previously shown for endogenous pathways (48). Further differences were 
identified between DU.4 and DU.8 for RBS strengths of BioC and BioH. Well-
performing DU.8 had balanced expression between the two genes (predicted TIR 
of 32,000 and 43,000 AU respectively) whereas DU.4 showed a skewed balance 
towards BioC (88,000 and 16,000 AU respectively). An additional unexpected 
mutation in the promoter region of DU.4 may add to mis-balancing of pathway 
intermediates, which could explain the very low production of this strain. 
 
In this Chapter, we have established protocols for nanoliter media, strain 
encapsulation, and producer extraction with a high survival rate using only sugar 
modification. We are confident that this workflow will simplify future screening - 
selection projects. 
  
 
  
 
Screening and selection: Applications for vitamin biosynthesis in E. coli 
 
 
 
55 
 
BIBLIOGRAPHY 
[1] Kwon KK, Yeom SJ, Lee DH, Jeong KJ, Lee SG. Development of a novel 
 cellulase biosensor that detects crystalline cellulose hydrolysis 
 using a transcriptional regulator. Biochemical and Biophysical 
 Research Communications 2018; 495(1):1328–34. 
 
[2] Casadaban MJ, Cohen SN. Analysis of gene control signals by DNA 
fusion and cloning in Escherichia coli. Journal of Molecular Biology 
1980; 138(2):179–207.  
 
[3] Patterson GH, Lippincott-Schwartz L. A photoactivatable GFP for selective 
photolabeling of proteins and cells. Science 2002; 297(5588):1873–7.  
 
[4] Siedler S, Khatri NK, Zsohár A, Kjærbølling I, Vogt M, Hammar P, Nielsen 
 C, Marienhagen J, Sommer MOAS, Joensson H. Development of a 
 bacterial biosensor for rapid screening of yeast p-coumaric acid 
 production. ACS Synthetic Biology 2017; 6(10):1860–9.  
 
[5] Peters G, De Paepe B, De Wannemaeker L, Duchi D, Maertens J, Lammertyn 
J, De Mey M. Development of N-acetylneuraminic acid responsive 
biosensors based on the transcriptional regulator NanR. 
Biotechnology and Bioengineering 2018; 115(7):1855–65.  
 
[6] Rogers JK, Guzman CD, Taylor ND, Raman S, Anderson K, Church GM. 
Synthetic biosensors for precise gene control and real-time 
monitoring of metabolites. Nucleic Acids Research 2015; 43(15):7648–
60.  
 
[7] Merulla D, Van Der Meer JR. Regulatable and modulable background 
expression control in prokaryotic synthetic circuits by auxiliary 
repressor binding sites. ACS Synthetic Biology 2016; 5(1):36–45. 
  
 [8] Kim HJ, Lim JW, Jeong H, Lee SJ, Lee DW, Kim T, Lee SJ. Development of 
a highly specific and sensitive cadmium and lead microbial biosensor 
using synthetic CadC-T7 genetic circuitry. i 2016; 79:701–8.  
56 
 
 
[9] Whangsuk W, Thiengmag S, Dubbs J, Mongkolsuk S, Loprasert S. Specific 
detection of the pesticide chlorpyrifos by a sensitive genetic-based 
whole cell biosensor. Analytical Biochemistry 2016; 493:11–3. 
 
[10] Jha RK, Kern TL, Fox DT, M. Strauss CE. Engineering an Acinetobacter 
regulon for biosensing and high-throughput enzyme screening in E. 
coli via flow cytometry. Nucleic Acids Research  2014; 42(12):8150–60.  
 
[11] Hong H, Park W. TetR repressor-based bioreporters for the detection of 
doxycycline using Escherichia coli and Acinetobacter oleivorans. 
Applied Microbiology and Biotechnology 2014; 98(11):5039–50.  
 
[12] Rohlhill J, Sandoval NR, Papoutsakis ET. Sort-Seq approach to 
engineering a formaldehyde-inducible promoter for dynamically 
regulated Escherichia coli growth on methanol. ACS Synthetic Biology 
2017; 6(8):1584–95.  
 
[13] Lehning CE, Siedler S, Ellabaan MMH, Sommer MOA. Assessing 
glycolytic flux alterations resulting from genetic perturbations in E. 
coli using a biosensor. Metabolic Engineering 2017; 42:194–202.  
 
[14] Hanna DA, Harvey RM, Martinez-Guzman O, Yuan X, Chandrasekharan B, 
Raju G, Outten FW, Hamza I, Reddi AR. Heme dynamics and trafficking 
factors revealed by genetically encoded fluorescent heme sensors. 
Proceedings of the National Academy of Sciences 2016; 113(27):7539–
44.  
 
[15] Rogers JK, Church GM. Genetically encoded sensors enable real-time 
observation of metabolite production. Proceedings of the National 
Academy of Sciences 2016; 1;113(9): 2388–93.  
 
[16] Hanko EKR, Minton NP, Malys N. A transcription factor-based biosensor 
for detection of itaconic acid. ACS Synthetic Biology 2018; 7(5):1436–
46.  
 
[17] Zhang J, Barajas JF, Burdu M, Ruegg TL, Dias B, Keasling JD. 
 
  
 
Screening and selection: Applications for vitamin biosynthesis in E. coli 
 
 
 
57 
 
Development of a transcription factor-based lactam biosensor. ACS 
Synthetic Biology 2017; 6(3):439–45.  
 
[18] Kasey CM, Zerrad M, Li Y, Cropp TA, Williams GJ. Development of 
transcription factor-based designer macrolide biosensors for 
metabolic engineering and synthetic biology. ACS Synthetic Biology 
2018; 7(1):227–39.  
 
[19] Younger AKD, Dalvie NC, Rottinghaus AG, Leonard JN. Engineering 
modular biosensors to confer metabolite-responsive regulation of 
transcription. ACS Synthetic Biology 2017; 6(2):311–25.  
 
[20] Chen J, Sun S, Li CZ, Zhu YG, Rosen BP. Biosensor for organoarsenical 
herbicides and growth promoters. Environmental Science and 
Technology 2014; 48(2):1141–7.  
 
[21] Siedler S, Schendzielorz G, Binder S, Eggeling L, Bringer S, Bott M. SoxR 
as a single-cell biosensor for NADPH-consuming enzymes in 
Escherichia coli. ACS Synthetic Biology 2014; 3(1):41–7.  
 
[22] Siedler S, Stahlhut SG, Malla S, Maury JÔ, Neves AR. Novel biosensors 
based on flavonoid-responsive transcriptional regulators introduced 
into Escherichia coli. Metabolic Engineering 2014; 21:2–8. 
 
[23] Cayron J, Prudent E, Escoffier C, Gueguen E, Mandrand-Berthelot MA, 
Pignol D, Garcia D, Rodrigue A. Pushing the limits of nickel detection 
to nanomolar range using a set of engineered bioluminescent 
Escherichia coli. Environmental Science and Pollution Research 2017; 
24(1):4–14.  
 
[24] Jha RK, Kern TL, Kim Y, Tesar C, Jedrzejczak R, Joachimiak A, Strauss CE. 
A microbial sensor for organophosphate hydrolysis exploiting an 
engineered specificity switch in a transcription factor. Nucleic Acids 
Research 2016; 44(17):8490–500.  
 
[25] Zhang C, Ye BC. A single fluorescent protein-based sensor for in vivo 2-
58 
 
oxogluatarate detection in cell. Biosensors and Bioelectronics 2014; 
54:15–9.  
 
[26] Kwon KK, Lee D-H, Kim SJ, Choi S-L, Rha E, Yeom S-J, Subhadra B, Lee J, 
Jeong KJ, Lee SG. Evolution of enzymes with new specificity by high-
throughput screening using DmpR-based genetic circuits and 
multiple flow cytometry rounds. Scientific Reports 2018; 8(1): 2659. 
 
[27] Mahr R, von Boeselager RF, Wiechert J, Frunzke J. Screening of an 
Escherichia coli promoter library for a phenylalanine biosensor. 
Applied Microbiology and Biotechnology 2016; 100(15):6739–53.  
 
[28] Liu Y, Zhuang Y, Ding D, Xu Y, Sun J, Zhang D. Biosensor-based 
evolution and elucidation of a biosynthetic pathway in Escherichia 
coli. ACS Synthetic Biology 2017; 6(5):837–48.  
 
[29] Li H, Liang C, Chen W, Jin JM, Tang SY, Tao Y. Monitoring in vivo 
metabolic flux with a designed whole-cell metabolite biosensor of 
shikimic acid. Biosensors and Bioelectronics 2017; 98:457–65.  
 
[30] Frei CS, Wang Z, Qian S, Deutsch S, Sutter M, Cirino PC. Analysis of 
amino acid substitutions in AraC variants that respond to triacetic 
acid lactone. Protein Science 2016; 25(4):804–14.  
 
[31] Li Y, Qian S, Dunn R, Cirino PC. Engineering Escherichia coli to increase 
triacetic acid lactone (TAL) production using an optimized TAL 
sensor-reporter system. Journal of Industrial Microbiology & 
Biotechnology 2018; 789–93.  
 
[32] Rosano GL, Ceccarelli EA. Recombinant protein expression in 
Escherichia coli: Advances and challenges. Frontiers in Microbiology 
2014; 5:1–17.  
 
[33] Hecht A, Endy D, Salit M, Munson MS. When wavelengths collide: bias in 
cell abundance measurements due to expressed fluorescent 
proteins. ACS Synthetic Biology 2016; 5(9):1024–7.  
 
 
  
 
Screening and selection: Applications for vitamin biosynthesis in E. coli 
 
 
 
59 
 
[34] Raman S, Rogers JK, Taylor ND, Church GM. Evolution-guided 
optimization of biosynthetic pathways. Proceedings of the National 
Academy of Sciences 2014; 111(50):201409523.  
 
[35] Gao H, Kim IW, Choi JH, Khera E, Wen F, Lee JK. Repeated production of 
l-xylulose by an immobilized whole-cell biocatalyst harboring l-
arabinitol dehydrogenase coupled with an NAD+ regeneration 
system. Biochemical Engineering Journal 2015; 96:23–8.  
 
[36] Zhang Z, Zhang R, Zou L, McClements DJ. Protein encapsulation in 
alginate hydrogel beads: Effect of pH on microgel stability, protein 
retention and protein release. Food Hydrocolloids 2016; 58:308–15. 
 
[37] Roberts TM, Rudolf F, Meyer A, Pellaux R, Whitehead E, Panke S, Held M. 
Identification and Characterisation of a pH-stable GFP. Scientific 
Reports 2016; 6:1–9.  
 
[38] Meyer A, Pellaux R, Potot S, Becker K, Hohmann H-P, Panke S, Held M. 
Optimization of a whole-cell biocatalyst by employing genetically 
encoded product sensors inside nanolitre reactors. Nature Chemistry 
2015; 7(8):673–8.  
 
[39] Song Y, Li J, Shin HD, Du G, Liu L, Chen J. One-step biosynthesis of α-
ketoisocaproate from l-leucine by an Escherichia coli whole-cell 
biocatalyst expressing an l-amino acid deaminase from Proteus 
vulgaris. Scientific Reports 2015; 5:1–11.  
 
[40] Wei G, Ma W, Zhang A, Cao X, Shen J, Li Y, Chen K, Ouyang P. Enhancing 
catalytic stability and cadaverine tolerance by whole-cell 
immobilization and the addition of cell protectant during cadaverine 
production. Applied Microbiology and Biotechnology. Applied 2018; 1–11.  
 
[41] Walser M, Pellaux R, Meyer A, Bechtold M, Vanderschuren H, Reinhardt R, 
Magyar J, Held M. Novel method for high-throughput colony PCR 
screening in nanoliter-reactors. Nucleic Acids Research 2009; 37(8): 
e57. 
60 
 
 
[42] Barker DF, Campbell AM. Use of bio-lac fusion strains to study 
regulation of biotin biosynthesis in Escherichia coli. Journal of 
bacteriology 1980; 143(2):789–800.  
 
[43] Pédelacq J-D, Cabantous S, Tran T, Terwilliger TC, Waldo GS. Engineering 
and characterization of a superfolder green fluorescent protein. 
Nature Biotechnology 2005; 24(1):79.  
 
[44] Paulsson J. Summing up the noise in gene networks. Nature 2004; 
427(6973):415. 
 
[45] Anderson Jc, Dueber JE, Leguia M, Wu GC, Goler JA, Arkin AP, Keasling 
JD. BglBricks: A flexible standard for biological part assembly. 
Journal of Biological Engineering 2010; 4(1):1.  
 
[46] Salis HM. The ribosome binding site calculator. Methods in Enzymology 
2011; 498:19-42.  
 
[47] Daâssi D, Rodríguez-Couto S, Nasri M, Mechichi T. Biodegradation of 
textile dyes by immobilized laccase from Coriolopsis gallica into Ca-
alginate beads. International Biodeterioration and Biodegradation 2014; 
90:71–8.  
 
[48] Smanski MJ, Bhatia S, Zhao D, Park Y, Woodruff BA, Giannoukos G, Ciulla 
D, Busby M, Calderon J…Gordon DB. Functional optimization of gene 
clusters by combinatorial design and assembly. Nature Biotechnology 
2014; 32:1241 
 
 
 
 
 
 
 
 
 
 
  
 
Screening and selection: Applications for vitamin biosynthesis in E. coli 
 
 
 
61 
 
CHAPTER THREE – INCREASING THE 
CELLULAR DEMAND FOR BIOTIN AS A 
SELECTION SYSTEM 
For confidentiality reasons, aspects of this chapter have been modified, 
Abstract 
Although auxotrophic selection is a conventional approach for strain engineering, 
synthetic auxotrophy is only recently emerging in the field of synthetic biology. 
We construct here two selection systems for biotin biosynthesis by genetically 
modifying the host strain so that the resulting phenotype itself serves as selection 
pressure. In both cases, this selection pressure is due to increased cellular 
demand for the essential target metabolite or its immediate precursor. We use 
this method of synthetic auxotrophy to screen two different libraries and the effect 
of E. coli’s natural mutation rate. 
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INTRODUCTION 
Modularity and bottlenecks 
To generate high titers of a target molecule in metabolic engineering, the 
individual steps of a biosynthesis pathway often require fine-tuning, especially for 
non-native products or 1000-fold increases to in vivo concentrations. Modularity 
is a conducive approach to addressing such targets: expression constructs can 
be readily exchanged and tested for increase in product and pathway 
intermediates. This identifies and addresses engineering bottlenecks in a rapid, 
iterative manner. In synthetic expression constructs, several variables affect a 
pathway module. On the sequence level, transcription rates are determined by 
promoter strength, concentration of inducer (if relevant), copy number of the 
carrying plasmid, codon optimization, and the rate of translation initiation based 
on RBS sequence8. On a metabolic level, optimal transcription levels can 
nevertheless lead to poor production due to lack of precursor or cofactor 
availability as well as the genetic background of the cell factory. Generally it is 
desired to have a well-balanced metabolic pathway that achieves the optimum 
capacity of product formation. An imbalance is often characterised by low yields 
and can be due to low enzyme activity, poor expression, or low precursor 
availability (Figure 1). 
Although low flux and pathway bottlenecks pose an engineering challenge, they 
can be used as a powerful selection tool. For example, low enzymatic activity can 
be compensated by high substrate availability (Figure 1B). Poorly expressed 
enzyme constructs can be used to identify pathway variants with high precursor 
concentration. Here, we construct a modular pathway for biotin biosynthesis 
(Figure 1A) and use a bottleneck BioB module to select variants that supply high 
amounts of precursor DTB. 
8  Additional variables, such as mRNA stability, folding efficiency, chaperone 
availability, or enzyme degradation, are not taken into account here as they are 
usually not considered part of the “toolbox” of metabolic engineering. This 
suitability of this approach is discussed elsewhere (22). 
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Figure 1: Factors contributing to pathway balance 
A: Example of the biotin biosynthesis pathway as a modular, synthetic expression 
construct. Two steps of the pathway to DTB are shown. To identify well-producing variants, 
an RBS and promoter library with expected diversity 272 explores the expression 
landscape of Gene 1, while Gene 2 is constitutively expressed. 
B: Idealised Michael-Menten curves explain the relationship between substrate availability 
and reaction rate. The darker line signifies an optimally expressed pathway step with a 
high rate of turnover. The light grey signifies an enzyme with suboptimal expression and 
therefore a poor reaction rate. At low substrate concentration (red dotted line), ~50% of 
Vmax is achieved. This low catalytic rate can be compensated by high substrate availability. 
C: A schematic of a simplified, two-step pathway is shown on the left under balanced 
conditions, where initial substrate (grey bar) availability for enzyme 1 (red, filled in) is 
higher than the maximum conversion rate as indicated by dotted line. Overall a high flux 
occurs through the pathway with only some loss of metabolite at enzyme 2 (yellow) with a 
high concentration of final product (blue bar). In the unbalanced pathway (right), enzyme 1 
(red outline) is badly expressed or inherently poorly active so that only partial conversion of 
the substrate occurs. Although enzyme 2 has a higher capacity for conversion, the low 
substrate availability means that the overall yield of the pathway is low (blue bar). 
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Expanding E. coli’s biotin auxotrophy 
Strains with auxotrophy for the target molecule can be desirable in strain 
engineering. In a fermentation setting, auxotrophic dependency can replace 
antibiotics to maintain a production plasmid. This may be preferable as large-
scale use of antibiotics is expensive and prone to mutation and cultivation of 
persister cells (1). Further, use of antibiotics can hinder regulatory approval for 
some processes and may also spread resistance genes into the environment (2). 
Finally, auxotrophic plasmid maintenance systems can provide genetic 
engineering tools for “safe for consumption” microorganisms such as the recently 
published ΔthyA strain of lactic acid bacteria (3). Synthetic auxotrophies9 are 
underutilized in metabolic engineering despite promising results for targets such 
as 1-butanol (4, 5). Here we showcase the utility of synthetic auxotrophy as a 
selection system for metabolic engineering. 
Biotin is essential for central carbon metabolism as it acts as a co-factor for the 
formation of malonyl-CoA, mediated by the bifunctional BirA ligase (cf. 
Introduction. In an auxotrophic strain (i.e. one incapable of synthesising the biotin 
moiety), biotin must be supplemented for growth. However the cellular demand 
for biotin is extremely low (6), much below production levels required industrially. 
Previously (7–10), mutations of the E. coli BirA sequence were generated and 
characterised. Of particular interest were those mutations which increase the 
intracellular demand for biotin and generate more auxotrophic strains. As BirA 
mediates biotin distribution in the cell, decreased binding efficiency or reduced 
catalytic ligase ability would lead to less optimal biotinylation of the AccB subunit 
and subsequently, a growth reduction (Figure 2 (11–14)). The growth reduction 
resulting from a poorly functioning BirA can be rescued by higher levels of 
intracellular biotin. We utilise a highly auxotrophic BirA mutation I207S to address 
the bottleneck BioB enzyme. We identify a plasmid with increased expression 
stability and interrogate a metagenomic library for heterologous sequences. 
9 A synthetic auxotrophy is a molecule dependency generated by rational strain 
engineering 
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Figure 2: The bi-functional BirA protein 
A - Functional domains of the E. coli BirA sequence, visualised at PROSITE (11). 
Shown is the ligase domain that transfers biotin to proteins, the DNA binding site, 
two biotin binding sites, and the mutation in red. 
B - Crystal structures (12) were obtained from uniprot with mutation highlighted in 
pink (visualisation via litemol (13). Inset shows crystal structure of dimerised 
complex after biotin binding (14). 
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MATERIALS AND METHODS10 
Bacterial strains and plasmids 
Four plasmid-based metagenomic expression libraries were used in this study 
(Ab01, F01, F03, Granja Pig) which were generated from soil or fecal samples. 
Construction of the libraries as detailed (15) included the isolation of 
environmental DNA from the respective samples, sonication to generate 1-3 kB 
fragments from obtained DNA, and blunt-ended cloning into expression plasmid 
pBS18. 
 
Table 2: Plasmids constructed in Chapter 2 
Plasmid Construction 
pBS18 pZE21 (15) 
pBS412 Amplification of kanamycin resistance cassette from pGEN49 (15) 
(oBS1283, oBS1284) 
Amplification of bioB from E. coli MG1655 genomic DNA 
Amplication of LacI and pSC101 region from pZS4Int-LacI 
(EXPRESSYS) (oBS1279, oBS1280) 
pBS479 Addition of ampicillin resistance cassette (oBS886, oBS887) 
pBS679 Addition of HindIII site with oBS1587 
 
Chemicals 
The HABA reagent (4'-hydroxyazobenzene-2-carboxylic acid) was obtained from 
Sigma-Aldrich. Streptavidin was obtained from Chemical Point. 
Optimised MAGE protocols 
The following protocol is modified from the published version (16).  
In rich 2xYT media with kanamycin, an overnight culture of the desired strain 
harbouring MAGE plasmid pBS136 is used to inoculate a fresh media culture with 
kanamycinat a 1:100 dilution. At cuvette OD600 = 0.5 - 0.6, protein expression is 
induced with 2% arabinose. 
After 30 min, culture is cooled, washed twice in ice-cold MQ, and 45 µl of cells 
used for electroporation with 10 µM oligo in a 1 mm cuvette at 1800 V. After 
recovery in SOC media, additional rounds of MAGE are carried out as desired. 
                                               
10 For general methods, please see Chapter 2. 
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BirA MT strains were generated with multiple rounds of MAGE using mOBS105 
and confirmed with sequencing. 
HABA assay for biotin equivalents 
To make the HABA mix, 2 mg/mL streptavidin is dissolved in 7.5 mL 1x PBS and 
mixed with 1.5 mg/mL HABA reagent dissolved in 2.5 mL 10 mM NaOH. This is 
mixed 1:1 with 100 µL cell supernatant from production cultures. Standards 
between 5-25 µM are included. Absorbance is measured at 500 nm. 
Confirming or reverting BirA MT 
The biotin requirement of a BirA MT strain is higher than biotin concentrations 
generally available in LB media. To check against loss of the mutation, strains 
are streaked out on LB agar plates and LB agar with 0.1 mM biotin. Colony 
formation should only be observed on the latter. To revert the BirA MT to the WT 
state, a single round of MAGE was performed with moBS314. Transformants 
were plated onto LB agar as a selection for successful mutation reversion. 
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RESULTS 
Poorly expressed pathway step as a selection 
Complementing biotin synthesis with a BioB plasmid 
To control biotin biosynthesis in E. coli, we knocked out the Δbio operon and 
replaced biotin synthase functionality with one of two BioB-expressing plasmid, 
pBS412 or pBS679. The differences between these two plasmids are i) pBS679 
is ampicillin-resistance whereas pBS412 is kanamycin-resistant for compatibility 
with secondary plasmids, and ii) pBS679 contains a HindIII restriction site to 
increase clonability. Plasmid expression removes BioB transcription from 
feedback repression. Feeding the immediate precursor DTB allowed us to control 
turn-over of the enzymatic step. To allow fine-tuning of the system, BioB 
expression was controlled by an IPTG-inducible T5lacO promoter. 
Both plasmids were characterised in strain BS1575 (Figure 3). In the experiments 
shown, production by both plasmids is comparable (Figure 3B-C, 0.9±0.01 
compared to 1.3±0.02 mg/L). However, meta-analyis of 283 experiments with 
pBS679 and 98 experiments with pBS412 show an improvement for plasmid 
pBS67911. To streamline experimental parameters, only production tests at 0.01 
mM IPTG and 100 mg/L DTB were included in the analysis, reducing the 
experimental number to 37 for pBS679 and 13 for pBS412; the remaining 
variable is production strain12. The mean titer for pBS679 resulting from 105 
biological replicates is 1.25±0.6 mg/L (range [0.27; 2.69]); mean titer for pBS412 
from 38 biological replicates is 0.86±0.5 mg/L (range [0.12; 1.54]). OD 
normalisation did not significantly affect the comparison. It was concluded that 
pBS679 not only gives higher titers but also produces in a more stable manner 
(CV = 48% versus 63%), although it is unclear why this is the case.  
11 From internal database. 
12 Assuming no differences due to experiment, equipment, etc. 
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Figure 3: Plasmid architecture and activity of two BioB plasmids 
A - Simplified schemes comparing the architecture of pBS412 and pBS67, both IPTG-
inducible expression plasmids for BioB. The main difference lies in the antibiotics 
resistance marker and the addition of a restriction site following BioB in pBS679. 
B - Strain BS1575 expressing BioB plasmid pBS412 was characterised for conversion of 
substrate DTB to biotin under set induction conditions (0.01 mM IPTG). Shown is biotin 
titers of a small-scale production experiment of a WT (light grey) and a mutant strain with 
improved FeS cluster supply (darker grey). The mutation both increases and stabilises 
the titer. Even at the lowest DTB concentration, the mutation increases the biotin titer. We 
exploit this for selection later in the chapter.  
C - Optimal IPTG induction was determined for BioB plasmid pBS679 in BS1575. At 
excess DTB concentrations, the effect of IPTG concentrations between 0 and 0.05 mM 
were tested, indicating an optimal induction at 0.01 to 0.03 mM. High expression levels of 
BioB are toxic to the cell. 
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A second aspect of these BioB plasmids is toxicity at high expression, observable 
by reduced end-OD and cell viability. This can be seen at concentrations of IPTG 
> 0.3 mM in Figure 3C. A previously obtained expression mutant enables both
higher catalysis and higher expression / lower toxicity (Figure 3B: WT KD =
0.7669 with R2 = 0.97; MT KD = 1.884 R2 = 0.986)13. This expression mutant was
found to have improved iron-sulfur cluster supply, indicating that the bottleneck of
BioB expression and the toxicity at high expression is involved with supplying or
regeneration of iron-sulfur clusters.
BioB modularity for selection 
A heterologous BioB from Pseudomonas putida (strain ATCC 47054 / DSM 6125 
/ NCIMB 11950 / KT2440) was inserted into the pBS679 backbone to generate 
pBS511 and characterised for activity in strain BS1575. To determine effect of 
expression and substrate on growth behaviour, strains were provided with high 
(10 mg/L = 47 µM), low (1 mg/L = 4.7 µM), or endogenous (assume <1 nM) DTB. 
Each condition was tested at 8 induction conditions [10, 1, 0.1 … 0]. No growth 
was observed for conditions less than 1 mg/L DTB or less than 0.1 mM IPTG, 
which is in stark contrast to plasmid pBS412 and pBS679. For these two 
plasmids in ΔbioB strains with the native pathway up to DTB intact, endogenous 
DTB levels and leaky expression (0 mM IPTG) is sufficient for full growth (data 
not shown). Activity of plasmid pBS511 was also tested on plates, where strains 
required ~2.5 mg/L DTB (10 µM) for full growth (data not shown).  
13 Fit and KD calculated in Prism using one-site binding model. Non-specific 
binding component was disregarded, as the limit of detection of biotin bioassay is 
too high to determine background biotin levels. 
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Figure 4: Controlling complementation using plasmid pBS511 
A - A simplified graphic of the pBS511 shows the pBS679 backbone (pSC101 origin of 
replication, ampR ampicillin resistance, IPTG-inducible Lac-5 promoter, HindIII site after 
gene insertion site) expressing heterologous BioB from P. putida. 
B - Plasmid pBS511 can complement a BioB KO strain to full growth only under 
conditions of high DTB availability (10 mg/L) and high induction (0.1 mM and above). 
Shown is growth (OD600) monitored over 24 hours. 
Comparing the protein sequences for E. coli and P. putida BioB indicated a 67% 
similarity with no differences in iron-sulfur cluster binding residues14. The 
causative difference in complementation may be ascribed to RBS strength, which 
is reduced 19-fold in the P. putida sequence (33,000 AU vs. 1764 AU). This 
indicates that the high DTB demand of pBS511 is due to low translation of the 
BioB sequence (Figure 1, above).   
The results shown in Figure 4 set up conditions to use growth-based selection of 
high DTB levels. We exploit this to identify high DTB pathways from a plasmid 
library of DTB producers. We generated a modular pathway plasmid with 
constitutive expression of bioFAD and a second ORF with heterologous bioC - 
14 Clustal Omega (23) 
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bioH from an unnamed organism (undisclosed), controlled by a library of 
promoter and RBS strengths (expected library size 272). As pBS511-
complementation for BS1575 only occurs at high DTB availability, we hoped to 
identify the best promoter-RBS combination. The selection was carried out by 
electroporating the plasmid library with either pBS679 or pBS511 into BS1575 
and plating out on minimal MOPS. Based on colony formation on LB (not shown) 
and selection plates (Figure 5A), the library with pBS679 had a total library size of 
15-25 K. On selective conditions (MOPS with ampicillin and kanamycin, 0.01 mM
IPTG), 10-12 K complemented auxotrophy. This indicates that between 40 to
80% of the plasmid library can complement the DTB requirement of pBS679 (<
1nM). The library with pBS511 had a total library size of 10-12 K. On selective
conditions, (MOPS with ampicillin and kanamycin, 0.1 mM IPTG), 250 members
fulfilled the much higher DTB demand of the plasmid (2.5 mg/L at 0.1 mM IPTG
on plates). This represents 2 - 2.5% of library.
Figure 5: Selection and characterisation of a DTB library 
A - Strains were transformed with ligation mix of library plasmids and good or poor BioB. 
Shown is colony formation at 1-fold and 10-fold dilution of the washed recovery mixture 
for library containing pBS679 (top row) or pBS511 (bottom row) on selection plates 
(minimal MOPS). The poor BioB valve strains only form colonies at the highest 
concentration of cells, approximately 100-fold less than the normal strains. 
B - Characterisation of the whole library compared to those that enabled growth with 
pBS511 indicate a shift of the distribution towards higher production (p<0.001, unpaired t-
test with Welch’s correction), even though the average production of each set is within 
error. Note that the whole library is 50-fold larger. 
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To confirm that the selected 2% of library members were indeed the top 
performers in terms of DTB production, 72 colonies of each transformation from 
selective plates were tested for concentrations of biotin equivalents15 in the 
supernatant. Based on the results (Figure 5B), the set of selected library 
members contained the highest producers of biotin equivalents and its highest 
10% percentile is higher than any tested members of the whole library. Based on 
the production data, growth of a strain with pBS511 is possible with 2.5 mg/L 
extracellular biotin equivalents or higher16. Theoretically, this is equivalent to 23% 
of the total library (16 out of 72 colonies produces more than 2.5 mg/L biotin 
equivalents). This high-producing segment of the library was enriched more than 
6-fold in the selection.
15 DTB, biotin, oxidised biotin species. 
16 Which correlates with the DTB requirement on minimal plates. 
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Increasing the demand for biotin selects stable expression 
variants of BioB 
From literature, we identified a mutant BirA sequence that increases the cellular 
demand for biotin. The mutation I207S was transferred into strain BS1575 using 
MAGE to generate BS1601. The cellular biotin demand was characterized. The 
increased biotin requirement was used to select for more stable expression 
plasmids for BioB. 
Biotin requirement of BirA strains in liquid media and plates 
The biotin demand of B1601 was characterised in liquid media (Figure 6) and on 
minimal agar plates (Figure 7A). Both conditions were supplemented with [0; 10 
µM] biotin. After 4 days incubation on plates at 37 °C, no cells grew at 0 mM 
biotin whereas good growth was observed at 2.5 µM biotin and above on the 
plates. Some colony formation occurred at 1 µM indicating this concentration as 
the cut-off for auxotrophy complementation. The biotin demand in liquid for 
growth within 24h was much higher: full growth was observed only at 500 µM 
extracellular biotin and an auxotrophic cut-off above 7.5 µM. The shorter time 
interval was chosen due to limitations of the liquid experiment set-up: the kinetic 
reads are carried out on 200 µL growth culture, which can evaporate at elongated 
experimental conditions. 
The auxotrophy of a BirA mt strain could also be complemented by a BioB 
expression plasmid in the presence of precursor DTB. The plating experiment 
was repeated with strain BS1601 carrying plasmid pBS679 (BS1874). Both 
parameters of the BioB reactions (precursor concentration and BioB induction 
level) were tested for auxotrophy complementation. At ideal induction conditions 
(0.01 mM IPTG), colony formation was characterised as a function of DTB 
availability (Figure 7B). Full complementation, i.e. identical growth on minimal 
agar plate as with supplemented biotin, was seen at 10 µM DTB. Concentrations 
of 2.5 µM DTB allowed some colony growth; 1 µM DTB allowed none.  
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Figure 6: Biotin requirement of BirA I207S mutant strain 
Left - Growth curves of strain BS1601 (BirA I207S, Δbio) in minimal media supplemented 
with biotin. Shown are two replicates for each concentration stated. Highest two growth 
curve corresponds to 500 µM, the 250 µM, etc. 
Right - Three thresholds of growth are identified for strain BS1601: inert (no growth) up to 
7.5 µM biotin, partial complementation (stinted growth) when supplemented between 10 
and 50 µM biotin, and full complementation (full growth) at a minimum of 500 µM 
supplemented biotin. In grey is a WT strain (BS1575, BirA WT, Δbio) for comparison 
showing full complementation at 1 nM biotin. Each curve represents the mean of four 
replicates. 
Alternatively, in conditions of excess precursor (Figure 7C), colony formation of a 
BirA mt strain could be characterised based on induction of BioB enzyme.  
Triplicate cultures of strain BS1874 were spotted (5 µL0at different dilutions at 
CFUs of 106/mL,105/ml, etc. on minimal MOPS plates with ampicillin and 50 µM 
DTB containing varying amounts of IPTG [0; 0.1 mM]. At no induction, the 
leakiness of the T7-lac promoter was sufficient to complement auxotrophy yet 
reduced growth is visible at lower cell concentrations (left spots compared to 
right). An increase in induction led to better growth in all spots up to 0.01 mM 
IPTG. At higher concentrations of IPTG, spot formation started to suffer due to 
expression toxicity; almost no survival was seen at 0.1 mM IPTG. This mirrored 
the behaviour of pBS679 in a BirA WT strain (see above). 
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Figure 7: Controlling auxotrophy complementation using plasmid pBS679 
A - The growth defect of a BirA mt strain can be alleviated by the addition of biotin at 1-
2.5 µM, quantified by colony formation on minimal agar plates with supplemented biotin. 
B - Further the strain can grow with supplemented biotin precursor DTB at 2.5 µM if 
expressing an inducible BioB plasmid at ideal induction of 0.01 mM IPTG.  
C - BioB expression is toxic to the strain at high levels (above 0.02 mM IPTG, quantified 
by spot assay) when supplemented with 100 mg/L DTB.  
The improved Fe-S cluster mutant shown above was previously isolated by 
plating BS1575 at high IPTG conditions to identify strains that could tolerate a 
higher BioB expression. We wanted to repeat this approach using a BirA strain as 
the previous selection round suffered from a high rate of false positives. Due to 
BirA auxotrophy, only functional BioB plasmids would allow for survival at non-
toxic IPTG concentrations (0.01 mM) and additional expression mutants would 
allow for colony formation at 0.1 mM IPTG. Strain BS1874 was plated out on 
selective conditions (0.1 mM IPTG) at densities of 109 CFUs, leading to the 
formation of ca. 300 colonies (selection 1 in 3.3M, data not shown).   
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Out of 300 colonies, 200 were tested for biotin production in the presence of 100 
mg/L DTB. 15% showed higher production than a non-selected strain (Figure 
8A). These were counter-screened for intact BirA mutation by ensuring biotin 
requirement was still elevated. Colonies were tested for production and assessed 
for stability across replicates. Four hits were identified for confirmation, yet did not 
perform better than the control (BS1575 + pBS679) when cured and re-
transformed with pBS679. Hence it was concluded that the increase in production 
seen in Figure 8C is due to mutations in the plasmid. Three plasmids were 
extracted and retransformed into BS1575. No increased titers were observed but 
a change in expression at different concentrations of IPTG was seen for plasmid 
pBS679* (Figure 8C). Sanger sequencing indicates an insertion resulting in a 
frameshift mutation for the last third of the gene sequence. However, as titers 
were not improved, we considered the hits from this selection round false 
positives. 
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Figure 8: A biotin selection system using engineered auxotrophy 
A - 200 colonies survived selection conditions (0.1 mM IPTG) and were tested for 
production. Biotin concentrations of supernatant were determined by bioassay using a 
Δbio E. coli strain and sorted by lower significance cut-off (mean - stdev). Compared to 
control strain (red, a BirA mt not subject to selective plating), 30 colonies showed higher 
production.  
B - Thirty colonies were chosen for further characterization based on increased titers with 
stable production. Shown is growth and biotin concentration for each strain at two 
induction conditions compared against control (grey bar, left) in each case. Note that 
strain phenotypes were reverted to BirA WT. Four strains were identified for further 
testing. 
C – Three plasmids were successfully isolated from improved strains identified in B and 
freshly transformed into BS1575. They were tested for production but no improved titers 
were seen at 100 mg/L DTB and the tested IPTG gradients. However, a more robust 
plasmid pBS679* was identified with less variability between replicates. 
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Functional metagenomic selection 
Functional metagenomic selection is the use of gene KOs to identify 
heterologous sequences to complement functionality. To interrogate a total of 
four 1 kB, plasmid-based metagenomic expression libraries for i) alternative 
BioBs sequences and ii) more efficient catalysis, we utilised a two-strain 
approach with BirA WT and MT strains. 
In two rounds of transformation of the plasmid libraries into either the BirA WT or 
MT strain, a total of >800,000 individual transformants (CFU’s on non-selection 
plates) were isolated. Transformation efficiencies were up to 7-fold higher for the 
BS1575 strain (700,000 CFUs versus 120 000 CFUs); we assume the slower 
growth of strain BS1601 impedes transformation rates. On selective plates 
(minimal MOPS with 1 µM DTB), colony formation indicated selection rates 
between 0.5 – 4% regardless of strain. We observed a high background rate on 
negative control plates (background strain with pBS679 plated onto minimal 
MOPS without DTB), which we ascribe to trace biotin contamination. Cross-talk 
of strains capable of biotin production lead to a halo-like formation around their 
colonies (Figure 9A). Colonies were restreaked and sequenced, identifying 16 
biotin synthases from Serratia spp. and Pseudomonas spp. (Figure 9B). Further, 
8 sequences showed the complementation phenotype but were not predicted 
biotin synthases following blastP and blastX analysis (17). No biotin synthases 
were isolated with the BirA MT strain. Although a total of 50 colonies appeared to 
complement functionality, sequenced revealed these as alternative BPL which 
removed the selection pressure of the screen (false positives).  
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Figure 9: Functional metagenomic selection with BirA MT or WT strains 
A – Overview of experimental set-up: Environmental DNA was shredded into 1 kB 
fragments and inserted into an expression backbone to generate the metagenomic 
libraries. These were transformed into Δbio BirA WT or MT strain and plated at minimal 
DTB concentration to identify clones that could complement the respective strain 
auxotrophy. An unexpected result from the plating was cross-talk from high producers 
which allowed false positives to grow around the colony in a halo formation. 
B – Phylogenetic tree of 16 BioB sequences identified in the BirA WT selection. 
C – Phenotypic characterization of the sequences expressed in the metagenomic plasmid 
backbone was carried out in the presence of 100 mg/L to determine production potential 
of the plasmids in the BS1575 backbone. Three of the hits gave non-zero production 
values (n=4). 
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Three plasmids showed non-zero biotin titers when transformed into BS1575 and 
tested for production in the presence of 100 mg/L DTB (Figure 9C). To test 
production capacity in a suitable backbone with balanced RBS and optimal 
induction conditions, the two annotated BioB sequences were transferred into the 
pBS679 backbone. Cloning was successful only for the sequence from Serratia 
liquefaciens (pBS1406). The sequence did not outperform E. coli BioB (pBS679, 
Figure 10). 
Using a functional metagenomics approach, we aimed to interrogate a library of 
metagenomic expression plasmids to identify i) any BioB sequences that could 
complement a ΔbioB knockout strain, and ii) improved BioB sequences that could 
complement a BirA WT under DTB conditions where E. coli WT could not. We 
identified 16 biotin synthases that functionally expressed in the E. coli host, but 
did not perform better than pBS679 when transferred to this plasmid backbone. 
Hence, none of these sequences would have been capable of complementing 
BirA auxotrophy under the selection conditions.  
The selection scheme would benefit from two modifications. Firstly, a larger 
metagenomic expression library may contain a broader diversity of biotin 
synthases. Secondly, the low transformation efficiency of the BirA MT strain may 
impede larger metagenomic screens. Optimising of the transformation protocol 
for this strain may be advisable. 
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Figure 10: Production of pBS1406 compared to pBS679 
Three biological replicates of strain BS1575 carrying either pBS679 or pBS1406 were 
tested for production based on IPTG induction in the presence of 100 mg/L DTB. 
Supernatant titers were analysed by bioassay. Error bars of strain carrying pBS1406 were 
too small to see.  
DISCUSSION 
Metabolic engineering aims to increase production and stability of cell factories. 
Understanding metabolite valves and modularizing pathway steps are common 
tools to reach this aim. Optimising flux through metabolite valves directs more 
resources from central carbon metabolism into the production pathway without 
negatively affecting growth and cellular upkeep (18–20). Modularity is used as a 
design concept to increase functionality, especially for the systematic 
biosynthesis of structurally related target compounds. For example, the 
engineering of glycosylation patterns for erythromycin production in E. coli (21) 
demands a methylation at C3 of each of the various substrates. In the work 
presented in this chapter, we utilise the tools of metabolic engineering (valves 
and modularity) yet reconfigure the main aim. We decrease strain production and 
through this, generate selection pressure. 
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The described selection systems were used to successfully interrogate different 
types of libraries. In the first part, a poorly expressed BioB produces biotin 
concentrations at the lower threshold of Δbio complementation. This construct 
was utilised to enrich a library of DTB producers and identify several high-
producing variants. In the second part, a synthetically engineered auxotrophy 
finds plasmid mutations that stabilize production but do not increase titers. 
Further, the engineered auxotrophy is used to test a plasmid library of 
metagenomic fragments for improved BioB variants. No BioB sequences 
performed better than the native E. coli sequence and could only be isolated with 
a BirA WT strain with no auxotrophic selection pressure. The strain with 
engineered auxotrophy may have been too stringent for the library.  Further, the 
BirA MT suffered from lower transformation efficiencies and a high rate of false 
positives. 
 
It should be noted that engineered auxotrophy as a selection system may not be 
suitable for metagenomic selections. In our case, the mutant BirA selection 
pressure was easily evaded by the expression of heterologous BPL sequences. 
These false positives quickly overwhelmed the selection system. Nevertheless, 
we are confident that the functional landscape of the metagenomic libraries was 
explored, as a superior BioB would have complemented the increased 
auxotrophy of the BirA MT and generated the halo formation which was seen in 
the BirA WT screen. 
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CHAPTER FOUR – A COUNTER-SCREEN 
FOR TOXICITY SELECTIONS 
This chapter is printed in its original form. 
Abstract 
In our biotin production strains, the bottleneck enzyme BioB is expressed under 
an IPTG-inducible promoter to control the trade-off between synthesis and 
toxicity. Over time, some of the strains have become IPTG inert in that they do 
not show the expected expression level at given induction conditions. We call this 
the “tuning phenotype” and have observed it caused by both plasmid- and 
genome-based mutations. To counter-screen for tuned strains, we generate a 
bioB-gfp transcriptional fusion and test for robustness in small-scale and 
shakeflask. Finally, we carry out a round of selection with the fusion plasmid and 
reduce the likelihood of false positives 3-fold.      
INTRODUCTION 
Selection systems rely on applying survival pressures to identify high producers. 
This can lead to false positives as mutated strains with loss-of-selection outgrow 
other strains. Loss-of-selection is attributable to the accumulation of mutations in 
production or selection modules. This is of particular relevance if PCR 
amplification is used, as the error rate of most polymerases is up to 10-fold higher 
than natural mutation (1), or if toxic genes are maintained on the plasmid. The 
growth advantage of losing a production or selection plasmid was quantified by 
an increase in growth rate by 30% in two independent studies (2,3). Without any 
selection pressure, plasmids were lost within 48h of continuous culture (2). 
 
To address the issue of loss-of-selection and false positives, counter-selection 
strategies are often employed. One type of counter-selection is the addition of 
selectable markers as kill switches: rpsL, galK, thyA, tetA, tolC, or sacB have 
been utilised. After a selection hit has been identified, the intactness of the 
selection system can be confirmed by the effect of the lethal gene. Other options 
include colourimetric assays such as xylE expression (4), or the nucleoside 
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kinase activity of herpes simplex virus thymidine kinase (hsvTK) which can 
restore cell growth when provided with substrate dP (1). A second type of 
counter-selection is redundancy to safeguard against escapees, as already 
discussed in Chapter 1. A further example is where low product concentrations 
led to cell death. For example, a system was built to find novel proteases were 
the desired enzymatic activity was coupled to b-lactamase secretion and resulting 
antibiotic resistance (5). 
 
In our set-up, selective pressure was generated by the toxicity of high BioB 
expression. 
After identification of an expression mutant which reduced toxicity and increased 
titers (detailed in Chapter 3), further rounds of “toxicity selections” were carried 
out. However, the scope of loss-of-selection and resulting 100% false positive 
rate impeded any additional rounds of this set-up, as all colonies that survived the 
toxicity challenged showed the tuning phenotype. Instead of constructing a 
counter-selection, we attempted to build a counter-screen that merely monitored 
BioB activity. For this we generated a transcriptional fusion of bioB with the gfp 
gene. Fusions with fluorescent proteins are excellent monitors of transcriptional 
activity if their expression does not lead to cellular burden. They have been used 
extensively to study bacteria, including promoter activity (6) or heterogeneity of 
single cell expression (7). Here we present their use as a monitor for the tuning 
phenotype. 
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MATERIALS AND METHODS17 
Bacterial strains and plasmids 
Table 1: Plasmids constructed in Chapter 4 
Plasmid Construction 
pBS683 Amplification of backbone from pBS679  
Amplification of sfGFP from pBS046 (oBS1590, oBS1591) 
pBS1058 Amplification of backbone from pBS679 (oBS2236, oBS2237) 
Amplification of sfGFP from pBS452 (obS2374, oBS2375) 
Shake-flask cultivations 
An overnight culture of relevant strains was started from single colony (biological 
duplicates) in 0.4 mL MOPS ampicillin with 1 µM biotin or DTB as appropriate. 
Using baffled flasks (Schott), 50 mL media (MOPS with ampicillin and 100 mg/L 
DTB) was inoculated from the overnight culture at a dilution of 1:50 and 
incubated at 275 RPM, 37 °C. Shake-flasks contained 0.01 mM IPTG for BioB 
plasmid cultures and GFP plasmid cultures, and 0 or 10 mM IPTG for BioB-GFP 
plasmid cultures. GFP plasmid cultures also contained 1 µM biotin. Samples 
were taken under sterile conditions at time-points 2, 4, 5.5, 7, 8.5, 10, and 24h 
and measurements of OD, fluorescence, and biotin concentrations in the 
supernatant were taken. 
17 For general methods, please see Chapter 2. 
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RESULTS 
Tuning plasmids - a problem 
Plasmids pBS412 and pBS679 expresses bioB, the bottleneck of biotin 
biosynthesis in E. coli (described in Chapter 3). The gene is expressed by a T5-
lac promoter. Increasingly high IPTG induction of the construct led first to growth 
reduction and then non-viable cells. In a separate work, toxicity of BioB was used 
as a selection system where high cell amounts were plated out on toxic IPTG 
conditions. It was hypothesised that colonies that could grow under the condition 
either i) reduced toxicity of BioB or ii) increased expression capacity of the strain. 
This approach led to the identification of a “expression mutation” that increased 
expression and allowed for higher production from the plasmids via improved 
iron-sulfur cluster supply. BS1575 contains this mutation.
Figure 1: Optimal IPTG induction can shift in strains after a round of toxicity 
selection 
Three daughter strains of BS1575 with pBS679 were obtained after a round of toxicity 
selection. Although none of them have higher titers than the control (in red), each strain is 
more resistant to IPTG induction. The concentration for optimal BioB expression 
(determined by titer) has shifted from 0.01 mM to 0.05 (light grey line) or 0.1 mM (darker 
grey lines) dependent on strain.  
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However, the selection led to a high rate of false positives wherein strains could 
grow on high induction conditions but did not have a higher production capacity 
(Figure 1). These hits have tuned expression of the toxic sequence so that they 
are less responsive to IPTG. Upon further characterization, 100% of “hit” 
plasmids show the tuning phenotype, which made further rounds of toxicity 
selections challenging. 
To explore the relationship between IPTG and the tuning phenotype, we exposed 
strain BS157418 with pBS679 to increased induction conditions passaged for 
three days in liquid media, then tested for production (n=36) with 100 mg/L DTB 
at their respective IPTG condition. We observed stable production across the 
replicates at the three lower conditions, with 1-2 outliers at the top (for 0.01 mM 
IPTG) or bottom (for 0.025 and 0.05 mM IPTG) range of the population. At the 
high induction conditions (0.1 mM), the tuning phenotype is visible for 8 colonies, 
corresponding to 22% of the population. From this experiment, we conclude that 
although the rate of emerging tuning phenotype is reduced in liquid media19, 
induction of 0.1 mM is a suitable set-up to explore this phenomenon further. 
Figure 2: High induction conditions generate the tuning phenotype 
A set of BS1574 strains with pBS679 was exposed to the stated IPTG concentrations by 
passaging for 3 days, then tested for production at 100 mg/L DTB at uninduced (grey) 
and respective induced (red) conditions. Titers were determined by bioassay. As the 
plate-to-plate variations of the bioassay increase at the lower limit of detection, all values 
were normalised to the respective lowest titer data point.  
18 Strain BW25113 with Δbio, expression mutant WT to simulate initial selection strain. 
19 Compared to the 100% false positive rate from the previous selections. 
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A construct that transcriptionally fuses BioB with a 
reporter gene 
In order to a) study the tuning phenotype more closely and b) generate a counter-
screen to re-enable toxicity selections in the future, we build a synthetic construct 
to transcriptionally fuse the bioB sequence with a reporter gene, in this case 
sfGFP. 
In the native biotin operon, bioBFCD are regulated by the same PB promoter. 
Gene bioB overlaps with bioF by four bases. Replacing the latter with gfp 
generates a transcriptional fusion bioB-gfp. Plasmid pBS1058 was constructed in 
this manner (Figure 3) yet otherwise mirrors the plasmid architecture of pBS679: 
IPTG-inducible GOI, low copy number origin, additional HindIII site, and ampicillin 
resistance. To utilise GFP output as a suitable indicator of BioB transcription, we 
needed to show that plasmid pBS1058 behaves in a parallel manner to pBS679 
in small-scale, plates, and shake-flasks.  
Figure 3: Fusion of BioB and GFP in plasmid pBS1058 
A - Plasmid map of pBS1058 showing IPTG-inducible bioB transcriptionally fused to a 
GFP reporter gene in a plasmid backbone with low copy number (SC101 origin of 
replication) and conferring ampicillin resistance. HindIII after GOI site not shown. 
B - Transcriptional fusion of the bioB and gfp genes mirrors the native E. coli bio operon 
for bioB and bioF sequences. Overlap visualised in Benchling. 
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Characterisation in small-scale and shake-flask cultivations 
In strain BS2163 (BS157420 with pBS1058), we characterized behaviour of the 
fusion plasmid for growth, production, and fluorescence based on IPTG induction 
(Figure 4) to compare to the activity of pBS679 (Chapter 3). We observed 
expression toxicity at high induction, no reduction in biotin titer compared to 
pBS679, and fluorescence mirroring BioB expression. However, the toxicity at high 
induction differed from pBS679 as it manifested as an increase in lag-time at 
concentrations of 0.1 mM IPTG and above instead of a reduction in end-OD and 
cell death21. We observed that fluorescence was maximally inducible even when 
lag-time toxicity was observed, indicating that GFP expression does not confer 
toxicity. This is confirmed with plasmid pBS683, which only expressed GFP 
under the T5lac-promoter and shows no toxicity (Figure 6). 
20 Experiments were carried out in the expression mutant WT strain (not FeS mutant 
strain BS1575) to mimic selection conditions. 
21 The effect of IPTG concentrations above 10 mM were not tested. 
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Figure 4: The GFP output of pBS1058 mirrors its BioB transcription 
A - Growth curves of BS2163 in the presence of 10, 50, or 100 mg/L DTB at no induction 
(top) or high induction (10 mM, bottom). Induction has a negative effect on growth by 
extending the lag-time but not end-OD or growth rates. An increase in lag-time was 
observed for replicates with 10 mg/L DTB.
B - A known expression mutant increases not only production titers (inset, mutant in red) 
but also fluorescence at all time points.
C - Comparing growth and fluorescence of BS2163 at three induction conditions indicates 
a trade-off between these two parameters. The left graph shows growth analogously to A. 
Again, lag-phase is extended at high induction. A medium induction condition (0.01 mM 
IPTG) does not lead to a visible phenotypic difference, indicating that growth is not 
affected by the medium induction conditions. However, the fluorescence output of the 
strain under no, medium, and high inductions (right boxes) shows that despite the growth 
deficiency, 10 mM IPTG induces the highest amount of fluorescence following 
exponential phase whereas the medium induction accumulates fluorescence more slowly 
and to a lesser degree.
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The plasmid was also tested in the expression mutant identified in previous 
rounds of toxicity selection (Figure 4B). As with pBS679, toxicity of pBS1058 is 
decreased in this strain. We observe a reduction in lag-time and increase in both 
fluorescence and titer in the MT strains. We also looked at the effect of DTB on 
plasmid pBS1058 and observed an increase in lag-time at high DTB and IPTG 
conditions (Figure 4A, bottom). Potentially, availability of the precursor increases 
activity of the BioB enzyme and therefore increases toxicity. We did not pursue 
this avenue further. We also characterised plasmid behaviour in shake-flask 
(Figure 5) to confirmed scalability. From the data we conclude that plasmid 
pBS1058 links transcription of bioB and gfp. 
Figure 5: Plasmid behaviour scales to shakeflasks 
A shake-flask experiment (n=2) was carried out to compare pBS697 (grey), pBS1058 at 
low (pink) and high (red) induction, and control pBS683 (blue). Shown is OD (lines), GFP 
fluorescence (bars), and biotin production (dots) as determined with the bioassay. Note 
that due to high fluorescence, the GFP values of pBS683 are 10% of their total values. 
After mutagenic conditions, the tool sieves out false 
positives 
To generate diversity, strain BS2163 (from here on referred to as BioB-GFP 
plasmid) was passaged for three days in minimal MOPS containing ampicillin, 
DTB (1 µM), and high levels of IPTG (10 mM). As controls, strains BS2385 (from 
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here on referred to as BioB plasmid) and BS2186 (from here on referred to as 
GFP plasmid) were also passaged22. 
Figure 6: Colony formation after toxicity of high induction 
Colony formation after IPTG induction of strain harbouring the GFP plasmid (top row) or 
BioB-GFP (bottom row). Both strains were exposed to either 0 or 10 mM IPTG for 3 days 
before plating on no induction (right) or 10 mM IPTG (left). Based on colony size, 
phenotypic diversity is discernible for BS2163 both not BS2186. Diversity can also be 
seen for individual colony behaviour under blue light (right photo): the majority of colonies 
show fluorescence visible to the eye (indicated by 1) whereas ~30% of colonies show no 
brightness (no expression of GFP, indicated by 2). 
Strains were plated out on minimal agar plates at high induction (10 mM for BioB-
GFP fusion and GFP control, 0.1 mM for BioB plasmid) conditions and incubated 
at 37 °C for 48 h (Figure 6). Diverse colony morphology was discernible for BioB 
plasmids and BioB-GFP fusion. The latter also showed where both highly 
fluorescent and non-fluorescent colonies. The quantify this diversity further, 92 
colonies of BS2163 were picked along with 46 colonies of the BioB and GFP 
controls. Further, it was noted whether the BS2163 colony in each position had 
lost fluorescence in the plating condition (~24% observed loss of fluorescence, 
Figure 6). A production test was carried out for the three strains to determine gain 
22 In each case, the BioB plasmid was induced at 0.1 mM IPTG. The GFP plasmid was 
supplemented with 1 µM BTN. 
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of phenotypic diversity based on three parameters under two conditions: growth, 
production, and fluorescence at leaky and high expression (Figure 7). 
Comparison of these values indicate that, taking end-OD as a determinant of 
fitness, all tested strains were amenable to the production conditions. Secondly, 
fluorescence was highly inducible for the GFP plasmid and as expression of GFP 
in this plasmid construct is not toxic, there is little metabolic pressure to affect 
expression levels or result in tuning. No fluorescence above background levels 
was observed for the BioB strain.  
We separated the BioB-GFP plasmid strains data into two sets, with or without 
observable GFP phenotype on the plate (Figure 8). Although the majority of non-
observable strains showed some fluorescence on the plate-reader, the maximum 
emission values reached no more than 25% of the expected values. This was 
mirrored by biotin titers: numbers were less than 25% of expected values. There 
was no observable correlation between GFP and titer of the non-fluorescent 
colonies. We compared titer and fluorescence of the observable fluorescence 
colony set and observed a robust correlation (n=70, R2=0.7) even after exposure 
to selective conditions.  
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Figure 7: Diversity in plasmid behaviour upon induction 
OD, fluorescence, and titer were calculated for each strain under induced (right) and un-
induced conditions (left). To aid the eye, BioB and BioB-GFP plasmid data were sorted 
lowest to highest based on induced titer, GFP plasmid was sorted based on induced 
fluorescence. Note that i) GFP plasmid contained 1 µM biotin in the production media, 
which is detected on some of the samples. ii) BioB plasmid is tested for production at 0.1 
mM IPTG, which is not optimal for this plasmid. 
In order to quantify the efficiency of the constructed counter-screen, we simulated 
a two scenarios of toxicity selection on the generated data (Figure 7 & 8). In each 
case, a random colony of BS2163 is picked and tested for production after 
exposure to toxicity conditions, i.e. high IPTG induction. Given the small number 
of colonies characterised in this data set, we assume no selection hits (variants 
with a higher production than the WT) and therefore divide the producers into 
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categories of poor or expected titers. A poor producer is here defined as 
producing less than 30% of the expected titer. 
Scenario 1 (Figure 8, top boxes) does not take the GFP behaviour of BS2163 into 
account. Based on the data shown (n=92), 29 colonies produced poorly, i.e. less 
than 0.7 mg/L at 0.1 mM induction. The likelihood when picking a random colony 
to obtain a poor producer is therefore 32%. In the second Scenario (Figure 8, 
bottom boxes) the GFP behaviour of BS2163 is taken into account. Therefore the 
colonies are pre-screened for fluorescence on selection plates prior to testing for 
production. This rules out 22 colonies of the total screen, leaving 70 colonies. 
Only 7 of these were poor producers such that the likelihood of randomly picking 
a poor producer is 10%. The group of library members characterised by high 
fluorescence were significantly different than the group as a whole (p=0.0134, 
non-paired Mann Whitney test, calculated in prism). From these data, we 
conclude that the BioB-GFP fusion is a successful tool to counter-screen for the 
tuning phenotype: the total number of colonies requiring production 
characterisation is reduced by over one third, and the likelihood of a tuned 
phenotype when utilising the screen is reduced 3-fold. 
Figure 8: The fusion plasmid is a robust tool for selection 
Left - Fluorescence and titer for BS2163 strain under induced and un-induced conditions 
based on whether colony fluorescence was visible (bottom) or not (top). The top boxes 
are considered “tuned”, i.e. IPTG inert. The colonies visualized in the bottom boxes 
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produce and fluoresce as expected. To aid the eye, plasmid data were sorted lowest to 
highest based on induced titer. 
Right – Correlation of titer and fluorescence of non-tuned strains indicate high robustness 
of the fusion (R2 = 0.68, n=70). 
DISCUSSION 
Loss of functionality arises in most biological systems when a “production load” is 
present, due to factors including protein misfolding, the cost of DNA and enzyme 
synthesis, toxicity of products, or misbalanced use of cofactors (3). The latter is 
pertinent to our system due to observed toxicity of BioB expression, which we 
hypothesise could be due to i) drain on endogenous iron-sulfur pools or ii) ROS 
generation during enzyme regeneration process. In our set-up, enzyme 
expression is coupled to an extracellular inducer, leading to loss of IPTG 
sensitivity as a first-response mutation.  
 
In previous work on loss-of-function, alleviation of production burden is shown as 
a highly effective countermeasure. The growth rate cost of plasmids could be 
diminished by expressing gene on the plasmid of choice to direct carbon flux into 
additional building block biosynthesis as a counter-balance for production burden 
(8). A second countermeasure is to reduce the mutation rate of the strain by 
deleting less reliable polymerases (9). Yet these measures are not feasible in our 
system, as we were relying on the toxicity of production and E. coli’s natural 
mutation rate to identify potential overproducers. To construct a compromise 
counter-screen for loss-of-function, we engineered an internal BioB monitor by 
transcriptionally but not translationally fusing the gene to sfGFP. This 
complemented our previous analytical methods of extracellular biotin 
measurement via bioassay and protein determination by proteomics by shedding 
light on BioB transcription in a semi-quantitative manner. Further, the fusion 
approach allowed us to study BioB toxicity under various conditions as GFP 
expression generated no additional burden on the system at high induction. This 
translates into minimal pressure to evolve the monitor plasmid, compared to 
antibiotic resistance of kill-switch systems with a high rate of escape. 
 
Upon characterisation, we observed that the BioB-GFP fusion plasmid was more 
stable to IPTG induction and had a high production capacity which surpassed 
that of pBS679 in some conditions. It is not clear why the addition of GFP 
 
  
 
Screening and selection: Applications for vitamin biosynthesis in E. coli 
 
 
 
103 
 
decreases toxicity of BioB expression. Hypotheses include stabilisation of BioB 
mRNA, gradiation of expression at lower concentrations, or an increased 
anaerobic environment due to the oxygen requirement of GFP maturation. 
Unfortunately, the stabilization by GFP has a result that the original toxicity 
screen using BioB induction could not be carried out with the fusion plasmid, as it 
was not possible to induce plasmid pBS1058 to toxicity. Nevertheless the plasmid 
is of high utility in other selections around the BioB gene, such as co-factor 
engineering via MAGE. Alternatively, the construct could be generated on a 
higher copy-number plasmid to reinstate BioB toxicity at high induction. Finally, 
the correlation between GFP and biotin titers was sufficiently robust that strain 
fluorescence could act not only as a counter-screen for tuning, but act as a 
screening tool itself, despite some changes in expression kinetics. Overall, we 
are confident that the BioB monitor plasmid described in this chapter is a suitable 
addition to the selection box for identifying biotin overproducers.  
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ANNEX 
Media and stock solutions 
10 MOPS 
Up to a total volume of 300 mL, 83.72 g of MOPS buffer and 7.17 g tricine were 
dissolved in MQ and buffered to pH = 7.4 using 10 M KOH (90% Reagent Grade, 
Sigma Aldrich) at a final volume of 440 mL. Fresh iron sulfate solution is made by 
dissolved 0.028 g FeSO4•7H2O in 10 mL MQ and added. To a final volume of 1l, 
salts are added: 50 m 1.9 M NH4Cl, 10 mL 0.276 M K2SO4, 5 µL 1M CaCl2•2H2O, 
100 mL 5M NaCl. Of the micronutrient stock, 0.2 mL is added. The media stock is 
sterile-filtered. 
  
10x M9 salts 
In a total volume of 1 L MQ, 68 g Na2HPO4 * 7H2O, 30 g KH2PO4 , 5 g NaCl, and 
10 g NH4Cl are dissolved and sterile-filtered.  
 
Vitamin solution 
Four solutions of 25 mL each of 0.238 g calcium pantothenate (Sigma-Aldrich) in 
MQ, 0.068 p-aminobenzoic acid (Sigma-Aldrich), 0.069 p-hydroxybenzoic acid 
(Sigma-Aldrich), and 0.077 2,3-dihydroxybenzoic acid (Sigma-Aldrich) all in KOH, 
were mixed, sterile-filtered, and aliquoted. 
  
Trace element solution 
In a total of 20 mL MQ, 11 mg ZnSO4 · 7H2O, 10 mg CuSO4 · 5H2O, 6 mg MnSO4 · 
H2O, 0.835 g FeCl3 · 6H2O, 11 mg EDTA disodium, 11 mg CoCl2 · 6H2O, and 40 mg 
CaCl2 · 2H2O are dissolved. Mixture can be heated to 60 °C if needed to aid 
solubilization. Solution is sterile-filtered 
 
10x TAE buffer 
In a total volume of 1L, 242 g Tris base (TRIZMA from Sigma-Aldrich), 57.1 mL acetic 
acid, and 100 mL 0.5M EDTA (Sigma) are mixed. 
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Strains mentioned in this thesis 
Strain name Plasmid Genotype 
 
BS1011 - BW25113 ΔbioB 
BS1013 
BW25113 
- lacI+rrnBT14 ΔlacZWJ16 hsdR514 
ΔaraBADAH33 ΔrhaBADLD78 rph-1  
Δ(araB–D)567 Δ(rhaD–
B)568 ΔlacZ4787(::rrnB-3) hsdR514 rph-1 
BS1020  BW25113 ΔyigM  
BS1093 pBS451 BW25113 ΔbioB 
BS1574 - BW25113 Δbio 
BS1575 - BW25113 Δbio Fe-S mutation 
BS1601  BW25113 Δbio BirA I207S 
BS1613 pBS910 
(CU.4) 
BW25113 Δbio, Fe-S mutation 
BS1874 pBS679 BW25113 Δbio BirA I207S 
BS2239 pBS679 BW25113 Δbio Fe-S mutation, ? 
BS2240 pBS679 BW25113 Δbio Fe-S mutation, ? 
BS2151 pBS679 BW25113 Δbio Fe-S mutation, ? 
BS2163 pBS1058 BW25113 Δbio 
BS2186 pBS683 BW25113 Δbio 
BS2385 pBS679 BW25113 Δbio 
sAS278  29Δglk2Δpts1ΔmanZ1ΔyigM 
Top10  F- mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 nupG recA1 araD139 
Δ(ara-leu)7697 galE15 galK16 rpsL(StrR) 
endA1 λ- 
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Oligos 
oBS020 CTGTACAAATGATGATCTAGAGGCATCAAATAAAACGAAAGGCTC 
oBS021 TTCGCCTTTACGCATAAGCTTAGAACCGCCTCCAG 
oBS768 ACCCCGGGGCUTCTCCAAAACGTGTTTTTTGTT 
oBS789 
ACTACCAUGCCACAAACCAGCTAAGGAGGTAAATATGAGCTGGCA
GGAGAAAATCAAC 
oBS886 TGATGTTGGCAGTTTTCTCG 
oBS889 
AATGGTTTCTTAGACGTCGGAATTGCCAGCGATTTCCCTCGAGGT
GAAGACGAAAG 
oBS1007 
GTCCCACCGCTTACCTCCTATTACGTCACTAATAGCTAAGGAGGT
AAATATGAATAACATCTGGTGGCAGACC 
oBS1105 ATGCGTGAGATCCAGCTT 
oBS1106 AAGATGAUCTTCTTGAGATCGTTTTGGTCT 
oBS1107 ACCCCGUAGGCGGCAAAGCCGTTTTTC 
oBS1159 ACTGAGCUAGCTGTAAACTAGCATAACCCCTTGGG 
oBS1160 ATGTGTTTGUTTATTTTTCTAAATACATTCAAAT 
oBS1161 ACAAACACAUTTCCCCGAAAAGTGCCACCTG 
oBS1162 ATCTCAAACUCAGGAGAGCGTTCACCGACAA 
oBS0768 AGCGGTTGAUGCGTAAAGGCGAAGAGCTGTT 
oBS0769 ATTGGGGUGCCTAATGAGTGAGCTAA 
oBS1105 ATCATCTUAAACGCCAGCAACGCGGCC 
oBS1172 AGGGGCGGGGUTTTTTTTTAGTGCTTCATGTGGCAGGAGAA 
oBS1173 ATTCCTCUACGCCGGACGCATCG 
oBS1159 ACTGAGCUAGCTGTAAACTAGCATAACCCCTTGGG 
oBS1160 ATGTGTTTGUTTATTTTTCTAAATACATTCAAAT 
oBS1279 ACCAAGCACUAGGGACAGTAAGACGGGTA 
oBS1280 ATCCCACUCCCCCTAGAGGCATCAAA 
oBS1283 AGCCATATUTACCTCCTTAGCTCTAGAG 
oBS1284 AGTGCTTGGUGATAGGGACTCGAGGTGAA 
oBS1435 
AACCAATUGAGGTCCGAGGGAATGAATGAATCTATTATAGGTACA
AAAAGATGCG 
oBS1440 AGTCTACCUTCAAGCGCCCGTTCACCATGCGTAAAGCAATCAG 
oBS1587 ACAAGCTUTCCCACTCCCCCTAGAGGC 
oBS1590 AAGCTTGUTCATCATTTGTACAGTTCATCCATACCATGCG 
oBS1591 AGAGATACUAGTTAGAGAACCTCCGATTTGAATC 
oBS2236 
ACTGCCAUCCACAGAACCTAAGAGCCGGATGATTAATTGTCAACA
CCATTTGCCAGCTGG 
oBS2237 
ACTGCCAUCCACACACGCTAAGAGCCGGATGATTAATTGTCAACA
CCATTTGCCAGCTGG 
oBS2374 AGCATTAUGAGAAAAGGCGAAGAGCT 
oBS2375 AGCTTGTTUTGTACAGTTCATCCATACCATG 
moBS314 
GCTTCCTGCAGCGTGATCCACCCCTGATTAACGACACTCTCTTCA
ACACGGCGCATTGCCATGTTGCTCCCGGCTCCAATGACTATTTGC 
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